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CHAPrER I 
INTRODUCTION 
Cancer is one of the leading causes of death in the Unites States, in spite of advances 
in cancer prevention and therapy. Recently, ion channels have been shown to be 
involved in the proliferative signalling mechanisms in various cell types. This 
dissertation is designed to investigate the roles of Ca2+ and K+ channels in tumor cell 
growth. Two frequently studied brain tumor cells were selected in this study: U-373 MG 
human astrocytoma and SK-N-MC human neuroblastoma cell lines. 
In order to study the roles of Ca2+ and K+ channels in the growth of tumor cells, a 
pharmacological approach was taken, i.e. the effects of various these ion channel agonists 
and antagonists on tumor cell growth were examined. Assessment of tumor cell growth 
was made by counting the number of cells using a hemacytometer. For clarifing the 
mechanism of action of these drugs, their cytotoxicity was assayed by the trypan blue 
exclusion method. 
Intracellular Ca2+ is known to modulate a variety of cellular functions including cell 
proliferation. The effects of growth-promoting agents on intracellular Ca2+ 
concentrations were studied to ascertain the role of intracellular Ca2+ in the proliferative 
signalling mechanisms in the tumor cell lines. Moreover, since Ca2+ and K+ channel 
activities may regulate directly or indirectly intracellular Ca2+, the effects of these ion 
channel modulators on the basal and agonist-induced elevations in intracellular Ca2+ 
concentrations were investigated in order to elucidate the mechanism of action of these 
drugs in the tumor cell growth. Intracellular Ca2+ concentrations were measured by 
2 
fluorophotometric methods using Fura-2 dye. 
The results of this dissertation show that growth-promoting agents caused elevations 
in intracellular Ca2+ concentration in a dose-dependent manner and that these increases 
were due to release of Ca2+ from intracellular stores. Further, the results illustrate that 
ca2+ and K+ channel modulators inhibited tumor cell growth in a dose-related fashion 
and reduced agonist-induced increased intracellular Ca2+ concentrations. These drugs did 
not induce significant alterations in basal intracellular Ca2+ concentration. The results 
suggest that an increase in intracellular Ca2+ concentration is an important proliferative 
signalling mechanisms and that the growth-inhibitory effects of ion channel modulators 
are at least partly due to the blockade of agonist-induced increase in intracellular Ca2+ 
concentration in the tumor cell lines used in this study. 
This dissertation contributes to the understanding of the roles of ion channels as 
targets of modulation of tumor cell growth. This information may be valuable to the 
field of cancer therapy. The role of agonist-induced Ca2+ mobilization from intracellular 
stores without Ca2+ influx in tumor cell proliferation supports the notion of the existence 
of a diversity of cellular responses that are mediated by intracellular Ca2+ signalling. 
CHAPTER II 
LITERATURE REVIEW 
A. Role of Cell Proliferation in Carcinogenesis 
Mounting evidence strongly supports the contention developed in 1914 that cancer 
results from genetic alterations (Boveri, 1914). Utilizing molecular biologic techniques, 
distinct genetic alterations have been identified in several types of cancers. These 
changes involve the activation of cellular oncogenes and the inactivation of tumor 
suppressor genes (Bishop, 1991). However, many etiologic agents (e.g. peroxisome 
proliferators, dioxin, estrogens, cyproterone and phenobarbital) do not directly cause 
genetic damage (Green, 1992). Similarly, some environmental agents associated with 
cancers do not directly damage DNA. Thus, although genetic damage is most likely an 
eventual common pathway to the development of cancer, other pivotal mechanisms 
contribute to carcinogenesis (Aaronson, 1991; Ames and Gold, 1990; Goustin et al., 
1986). Moreover, various genetic changes can occur only during cell division (Preston-
Martin et al., 1990). 
Although cancer arises from defective control of cell proliferation, the etiologic and 
pathogenetic role of cell proliferation has received relatively little attention. Neverthless, 
as early as 1953, Nordling (1953) stated that the likelihood that certain types of cancers 
would develop could be greatly augmented by sustaining cell proliferation of the target 
tissue. A decade ago, a specific role for cell proliferation was integrated into a 
carcinogenesis model developed by Moolgavkar and cowokers (Moolgavkar and 
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Knudson, 1981; Moolgavkar et al., 1990), which was derived from epidemiologic data. 
Greenfield et al. (1984) and Cohen and Ellwein (1990) formulated a biologically similar 
model, using data from animal experiments. Both models quantify genetic and 
proliferative events and thus, offer insight into assessments dealing with the risk of 
developing cancer. In the context of these models, an agent can alter the likelihood of 
developing a cancer in only two ways: it can increase the probability of irreversible 
genetic damage occurring during cell division; and/or it can increase cell proliferation, 
usually accompanied by an increased cell number, and consequently increased number 
of opportunities for spontaneous genetic damage. 
Increased cell proliferation appears to be necessary for hormonally related tumors 
(Henderson et al., 1982). Hormones govern a number of cellular functions including cell 
proliferation and growth. Clinical and epidemiologic studies demonstrate that sustained 
hormonal stimulation and consequent enhanced cell proliferation result in estrogen-
dependent endometrial (Ziel and Finkle, 1975) and breast carcinomas (Russo et al., 
1990), thyroid stimulating hormone (TSH)-dependent thyroid tumors (Hill et al., 1989) 
and androgen and estrogen interactions in the development of prostatic cancer (Bosland, 
1988). Chronic increased cell proliferation induced by estrogen also increases the 
appearance of benign and malignant hepatocellular tumors in experimental animals and 
humans (Barrows et al. , 1988). 
Most virally related human tumors are also a result of sustained increased 
proliferation. Some RNA retroviruses can produce cancer without carrying a specific 
oncogenes as part of their RNA (Varmus, 1988) by increasing the proliferation of the 
5 
target tissue. Transmission of virus occurs from cell to cell, eventually resulting in the 
interposition of virally generated DNA next to a cellular oncogene. Thus, sustained cell 
proliferation and, ultimately, tumors can arise. Several DNA viruses, including hepatitis 
B virus (HBV) (Beasley, 1988; Dunsford, 1990), human papilloma virus (HPV) (zur 
Hausen, 1989) and Epstein-Barr virus (EBV) (Henderson, 1989) are associated with 
certain type of cancers in humans. In each instance the development of the malignancies 
results from a sustained proliferation of the target cells. For example, HBV-related 
hepatocarcinogenesis is probably not related directly to a specific oncogenic DNA 
alteration induced by the virus itself. Transgenic mice that overproduce the large 
envelope polypeptide of HBV, accumulate hepatitis B surface antigen and develop 
chronically active hepatitis, regenerative nodules and ultimately hepatomas (Dunsford, 
1990). This protein has none of the characteristics of oncogenes or tumor suppressor 
genes, but rather appears to be involved in the development of hepatocellular necrosis, 
chronic active hepatitis and sustained, increased hepatocyte proliferation. 
Increased cell proliferation also appears to contribute to the development of tumors 
secondary to various chemical exposures in humans, including cigarette smoking, snuff 
use, betel-quid chewing, aromatic amines, polycyclic aromatic hydrocarbons and 
nitrosamines (IARC monograph, 1975). Cigarette smoking is known to cause bladder 
cancer in humans, perhaps due to a hyperplastic effect on the urothelium of many 
cigarette smokers, in addition to the probable genotoxic damage that occurs (Auerbach 
and Garfinkel, 1989). 
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B. Signal Transduction Mechanisms in Cell Proliferation 
Extracellular factors such as hormones, growth factors, cytokines and the 
extracellular matrix appear to play a decisive role in determinations whether the cell will 
proliferate or differentiate (Rozengurt, 1989; Rozengurt, 1986; Rozengurt and Ober, 
1990). In order to understand how cell proliferation is controlled, it is necessary to 
identify the key pathways that convey extracellular signals to the nuclei, where repression 
of the differentiation program and induction of essential genes needed for cell cycle 
progression and replication are executed. The components of the pathways include the 
signalling network, from growth factors, growth factor-receptor tyrosine kinases, 
cytoplasmic protein kinases, OTP-binding proteins, to nuclear transcription factors 
(Karin, 1992). The signalling pathways show multiplicity as is illustrated by the 
cooperation between oncogenes (Hunter, 1991) or by the synergy observed between 
growth promoting agents (Rozengurt and Mendoza, 1985; Whitfield et al., 1987). 
Although cooperation between distinct classes of growth factors appears to be the rule, 
some mitogens are so effective that they can act alone (Pouyssegur and Seuwen, 1992). 
One of the major incentives for studying factors that regulate the processes of 
proliferation and differentiation is the recognition of their potential contribution to 
tumorigenesis - a premise that has been reinforced by the detection of growth factor 
secretion by many types of tumor cell (Gross et al., 1990; Herlyn and Malkowicz, 
1991). 
Growth factors initiate their action by binding to specific cell surface receptors. 
These activated receptors mediate a cascade of rapid biochemical and physiological 
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changes in the cell, which ultimately lead to DNA synthesis and cell proliferation 
(Reviwed in Rozengurt, 1986; Rozengurt, 1989). One of the immediate consequences 
of growth factor-receptor interaction is protein phosphorylation. The receptors for 
growth factors, like epidermal growth factor (EGF) and platelet derived growth factor 
(PDGF), are transmembrane glycoproteins that process intrinsic and ligand-stimulated 
protein tyrosine kinase activity. This intrinsic tyrosine-specific kinase activity is shared 
with several viral oncogene products, such as the transforming protein of Rous sarcoma 
virus. Other immediate consequences of receptor activation include cytoplasmic 
alkalization via activation of the Na+ /H+ anti port and increases in intracellular cyclic 
AMP levels, and the degradation of phosphoinositides to produce inositol triphosphates 
(IP3) and diacylglycerol (DAG). These degradation products, in tum, affect the release 
of Ca2+ ions from intracellular stores and the activation of protein kinase C (PKC), 
respectively. 
Receptor Tyrosine Kinases 
A large number of serum growth factors stimulate cell proliferation by interaction 
with a family of cell-surface receptors that possess an intrinsic, ligand-sensitive, protein 
tyrosine kinase activity (Carpenter, 1992; Yarden, 1988). These receptor tyrosine 
kinases (RTKs) comprise an extracellular ligand-binding domain that is linked directly 
to a cytoplasmically oriented, catalytic domain, which not only transduces a hormonal 
signal but also generates a biochemical message. The RTKs remain active following 
incorporation of growth factor-receptor complexes into endocytic vesicles, suggesting that 
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internalization of activated kinase may allow its interaction with cytoplasmic substrates 
(Cohen and Fava, 1985). 
Three proteins that serve as tyrosine kinase substrates are related by the presence of 
sequence motifs termed SH, or src homology, domains (Koch et al., 1991). Receptor 
tyrosine kinase substrates that contain SH regions do require localization at the 
cytoplasmic face of the membrane for activity. Two of these are enzymes that modulate 
the metabolism of phosphoinositides: phospholipase-C-'Y 1 (PLC-'Y 1) and 
phosphatidylinositol 3-kinase (PI3-kinase). Third substrate, termed rasGAP, is a 
molecule that modulates the GTPase activity of ras. 
Tyrosine kinase substrates seem likely to have key roles in the signal transduction 
pathway that regulates cell proliferation. For example, by means of removing effectively 
tyrosine phosphorylation sites in PLC-'Y 1, this site-directed mutagenesis abrogated growth 
factor-induced inositol phosphate formation and reduced the growth factor response by 
50% (Kim et al., 1991). In addition, an involvement of tyrosine phosphorylation in 
proliferation is supported by data showing that vanadate, an inhibitor of tyrosine 
phosphatases (Swarup et al., 1982 ), can enhance growth factor-induced DNA synthesis 
(Smith, 1983). 
Phophatidylinositol Turnover 
Some growth factors also stimulate intramembrane lipid metabolism (Berridge, 
1987). The activation of two distinct classes of receptors (G protein-coupled and 
intrinsic tyrosine kinase receptors) evokes the apparently identical response (i.e. 
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polyphosphoinositide (PPI) hydrolysis with marked preference for phosphatidylinositol 
4,5-bisphosphate, PIP:z) through the activation of PLC. 
Four distinct families of PLC are known, classified as a, (3, 'Y and o by Rhee and 
associates (Rhee et al., 1989). Of these, (31 has recently been identified as the isoform 
activated by hormones and neurotransmitters via the pertussis toxin-insensitive G proteins 
of the Gq family (Stemweis and Smrcka, 1992). Other PPI hydrolysis-coupled receptors 
operate via pertussis toxin-sensitive G proteins, however, and in this case the specific 
PLC involved has not been identified. In contrast to the others, the PLC-'Y 1 isoform is 
unable to interact with G proteins but rather binds to and is tyrosine phosphorylated by 
both the epidermal growth factor (EGF) and platelet derived growth factor (PDGF) 
receptors (Carpenter, 1992). Tyrosine phosphorylation of the PLC-'Yl isoform appears 
to permit the interaction of the enzyme with its substrates. 
Functional significance of this signalling pathway can arise from the fact that drugs 
which act as tumor promoters, such as phorbol esters and thapsigargin, are known to 
work by mimicking the effects of second messengers generated by PPI hydrolysis. 
Phorbol esters and thapsigargin can exert their action by stimulation of PKC and 
discharge of the Ca2+ stores sensitive to IP3 via blockade of the store-specific Ca2+ -
ATPase, respectively (Nishizuka, 1986; Thastrup et al., 1990)). Moreover, in cultures 
of rodent fibroblasts, growth is stimulated by overexpression of PKC (Housey et al., 
1988) or 5-HT1c receptor coupled to PPI hydrolysis via G proteins (Julius et al., 1989). 
The cell growth is also increased by overstimulation of a G protein-coupled receptor (e.g. 
the bombesin receptor (Rozengurt and Sinnett-Smith, 1983)). Finally, microinjection of 
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either PLC ({j or -yl) or antibodies against PLC--yl in NIH 3T3 cells induced bursts of 
cell division or blocked cell growth, respectively (Meldolesi and Magni, 1991). 
JP3 and Calcium 
IP3 induces the release of Ca2+i from the Ca2+ storing pool, i.e., the endoplasmic 
reticulum (Berridge, 1987). Addition of PDGF to cells induces a rapid and transient rise 
in Ca2+i (Moolenaar et al., 1986; Villereal and Byron, 1992). This response does not 
require external Ca2+ and, thus, presumably is mediated by IP3 which is also increased 
in PDGF-treated cells. Elevations in cytosolic Ca2+ in response to EGF have been 
detected in several cell lines (Moolenaar et al., 1986; Villereal and Byron, 1992) in most 
cases, removal of Ca2+ from extracellular medium abolished this effect, suggesting that 
EGF increases cellular Ca2+ by enhancing Ca2+ uptake. Thus, PDGF and EGF may 
modulate Ca2+i levels via different mechanisms. 
An optimal level of extracellular Ca2+ is required for the proliferation of cells in vivo 
(Rixon and Whitfield, 1976) and in vitro (Boynton et al., 1984). The level of Ca2+ 
appears to vary depending on the origin of the cells. The extracellular Ca2+ is required 
at two brief and distinct points through the cell cycle (Boynton, 1988). The first Ca2+ -
dependent state occurs immediately after stimulation of quiescent cells with serum and 
is referred to as GO-G 1 transition, while the second Ca2+ -dependent state is late in the 
prereplicative period immediately before DNA synthesis, and is referred to as the G 1-S 
transition. 
The mechanism of calcium action in cell proliferation may be related to at least four 
11 
cellular constituents (Villereal and Byron, 1992). The first is calmodulin, a Ca2+ -binding 
protein which upon binding Ca2+ undergoes a conformational change that enables the 
protein to activate numerous enzymes (Carafoli, 1985). The second is cyclic AMP 
which, althrough not directly affected by Ca2+ ion, can indirectly be affected either 
through calmodulin activation of adenylate cyclase or cyclic AMP phosphodiesterase. 
The third is PKC which is activated by the joint effects of Ca2+, phosphatidylserine and 
DAG. Lastly, there is an omithine decarboxylase (ODC) which is the rate-limiting 
enzyme in polyamine biosynthesis and whose increased activity may be a necessary 
requirement for normal trophic response. The Ca2+ seems to be involved in the 
induction of ODC (Ginty and Seidel, 1989). 
Diacylglycerol and Protein Kinase C 
Diacylglycerol activates the enzyme protein kinase C by increasing the affinity of the 
kinase for Ca2+ and phosphatidylserine (Nishizuka, 1984). PKC, a serine and threonine 
kinase, is directly activated by the tumor promoter, 12-0-tetradecanoyl phorbol-13-
acetate {TPA) and presumably acts as a binding site and cellular mediator of TPA 
(Kikkawa et al., 1984). Activation of PKC by TPA or DAG requires translocation of 
the kinase from the cytosol to the plasma membrane; recruitment is potentiated by Ca2+ 
(Wolf et al., 1985). Membrane associated PKC is rapidly degraded and is not detectable 
in cells for several hours following treatment with TPA (Ballester et al., 1985). PKC is 
preferentially associated with membranes in exponentially growing cultures, whereas in 
quiescent cells, it is mainly cytosolic (Adamo et al., 1986). The evidence implicating 
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PKC in the mediation of cell proliferation is that direct activation of PKC by TPA has 
been shown to inhibit differentiation of cultured cell lines (Hollstein and Kamasaki, 1986) 
and enhance proto-oncogene expression (Cross and Dexter, 1991). TPA has also known 
to induce many characteristics associated with the transformed phenotype including 
morphological transformation (Gainer and Murray, 1986), enhanced DNA, RNA, and 
protein synthesis (Hollstein and Kamasaki, 1986), increased secretion of plasminogen 
activator (Wigler and Weinstein, 1976) and increased polyamine synthesis (O'Brien and 
Diamond, 1977). 
Two major lines of evidence indicate that PKC activation constitutes a mitogenic 
signal-transduction pathway at least in Swiss 3T3 cells. First, the mitogens, PDGF, 
bombesin, vasopressin, and serum activate PKC as measured by a rapid increased 
phosphorylation state of an acidic 80 KD cellular protein. This protein provides a 
specific signal for PKC stimulation in intact and quiescent cells (Erusalimsky et al., 
1988). A second approach to investigate the role of PKC in the cellular proliferative 
response, is to exploit the selective loss of this enzyme caused by prolonged treatment 
of cells with phorbol esters. Chronic exposure of Swiss 3T3 cells to phorbol esters leads 
to a marked decreased number of specific phorbol ester-binding sites and to the 
disappearance of measurable PKC activity in cell-free preparations (Rozengurt, 1986). 
Such treatment prevents the increased 80.KD protein phosphorylation and the stimulation 
of DNA synthesis on subsequent additions of either phorbol esters, 1-oleyl-2-
acetylglycerol (OAG; synthetic DAG) or bombesin. 
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Cyclic AMP 
The actions of cyclic AMP are mediated by cyclic AMP-dependent protein kinase, 
which exists as two isozymes differing in their regulatory but not in their catalytic 
subunits (Flockhart and Corbin, 1982). Binding of cyclic AMP to the regulatory subunits 
releases and, thus, activates the catalytic subunits. Cyclic AMP has been reported to 
both stimulate and inhibit the growth of cultured cells (Dumont et al., 1989; Rozengurt 
and Ober, 1990). In an efforts to reconcile conflicting data, several investigators 
systematically analyzed the effects of elevated levels of cyclic AMP on synchronously 
cycling cells and found that the response elicited by cyclic AMP reflected the position 
of the cells in the cell cycle, the extent to which cyclic AMP was increased and the 
duration of the increase (Dunmont et al., 1989). 
A positive mitogenic effect of cyclic AMP is missing in many conventional cell 
culture systems and negative effects are common. Such opposite effects of the cyclic 
AMP cascade in different systems might perhaps be explained by a variation in the 
optimal concentration of cyclic AMP required, which would confer a biphasic feature to 
cyclic AMP action (Whitfield et al., 1987). Alternatively, the effect of cyclic AMP may 
depend on the differentiation state of the cell. Positive and negative regulatory elements 
have been demonstrated in the promoter of a growth-related gene and could depend on 
the differentiation state of the cell. It is interesting in this regard that the growth of 
many cancer cells is often inhibited by increasing cyclic AMP, whereas the proliferation 
of normal cells is often stimulated (Olashaw and Pledger, 1988). 
The regulatory subunit of cyclic AMP has been shown to possess topoisomerase 
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activity (Constantinou et al., 1985) and, thus, may play a role in gene transcription. In 
support, recent studies have demonstrated homology between the regulatory subunit of 
type II cyclic AMP-dependent protein kinase and the procaryotic cyclic AMP receptor, 
a protein that specifically binds DNA when complexed to cyclic AMP (Nagamine and 
Reich, 1985). Cyclic AMP has been shown to affect the expression of several genes, 
including the ras oncogene (Dere et al., 1986); whether these changes result from 
interaction of the regulatory subunit with DNA or from phosphorylation of DNA binding 
proteins by the catalytic subunit is not clear. 
Na+ -H+ Antiporl and Cytoplasmic Alkalization 
The term antiport is used to describe a transport mechanism which facilitates the 
movement of two substances in opposite directions across a membrane. The Na+-H+ 
antiport regulates the electrically neutral exchange of one Na+ for one H+ across the 
plasma membrane. The exchange is driven by the electrochemical gradients for Na+ and 
H+ and does not utilize energy directly. Under physiological conditions the intracellular 
concentration of Na+ is kept low by the Na+-K+ pump, and the antiport mediates the 
entry of Na+ into the cell and the efflux of H+. If the gradient for Na+ and H+ are 
reversed, however, the exchange can occur in the opposite direction. Intracellular pH 
also affects a modifier site which alters the Na+ -H+ antiport allosterically. Antiport 
activity is inhibited by the potassium sparing diuretic amiloride and its analoges, which 
compete with Na+ for its binding site (Reviewed in Grinstein et al., 1989; Moolenaar, 
1986). 
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The addition of mitogens to quiescent cells results in stimulation of the Na+-H+ 
antiport and an increased intracellular pH. In Swiss 3T3 cells intracellular alkalization 
occurs after the addition of a variety of mitogens. Thus, serum, the tumor promoter 
phorbol dibutyrate, vasopressin, PDGF, insulin, EGF and the neuropeptide bombesin 
increase intracellular pH by 0.1-0.3 units (Hesketh et al., 1988). Similar activation of 
the antiport have been reported by endothelin in vascular smooth muscle cells 
(Lonchampt et al., 1991), growth factors in a pancreatic cell line, AR 4-2J (Delvaux et 
al., 1990) and granulocyte-macrophage colony-stimulating factor (GM-CSF) in normal 
murine bone marrow macrophages (Vallance et al., 1990). 
The importance of the Na+-H+ antiport in the proliferative response has been 
emphasized many reports from several laboratories. For example, in hamster fibroblasts 
the half maximal concentrations for inhibition of the Na+ -H+ antiport by amiloride 
analogues correlated well with their half maximal concentrations for the inhibition of 
DNA synthesis (L' Allemain et al., 1984). 
Several lines of evidence strongly suggest that activation of Na+-H+ antiport by 
external stimuli is mediated by PKC. First, biologically active phorbol esters like TPA 
stimulate Na+-H+ antiport and, thereby, raise intracellular pH in a wide variety of cell 
types (Grinstein et al., 1989). Second, the addition of a synthetic DAG can mimic 
phorbol esters in rasing intracellular pH (Nishizuka, 1984). Furthermore, 
trifluoperazine, an inhibitor of PKC in vitro, can block the activation of Na+ -H+ antiport 
by external stimuli (Moolenaar, 1986). 
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Expression of c-fos And c-myc Proto-Oncogenes 
Jn addition to the events in the plasma membrane and cytosol, growth factors induce 
the expression of a set of cellular genes. These genes have been referred to as cellular 
immediate early genes or primary response genes (PRGs) (McMahon and Monroe, 1992). 
One common characteristics of PRGs is that their transcriptonal induction does not 
require de novo protein synthesis. This suggests that stimulus-induced posttranslational 
modification of preexisting regulatory proteins is sufficient for coupling of receptor-
linked second messenger pathways to PRG induction (Herschman, 1991). A second 
characteristic of this class of genes is that their rapid but transient induction occurs in a 
wide variety of cell types in response to growth or differentiation factors (Herschman, 
1991). 
Proteins encoded by c-fos function with those encoded by c-jun by forming a dimer, 
generally referred to as the AP-1 transcription factor (Karin, 1992). Dimer formation 
occurs via an amino acid domain referred to as a leucine zipper, which is composed of 
an a helix containing four leucine residues spaced at every seventh amino acid (Karin, 
1992). DNA binding by dimers occurs by means of a region rich in basic amino acids 
that lies adjacent to the leucine zipper domain (Karin, 1992). One mechanism by which 
AP-1 dimers affect transcription is dependent upon binding of their basic domains to a 
short DNA sequence (TGACTCA), referred to as the TRE (TPA response element) 
(McMahon and Monroe, 1992). 
Chronology of activation and deactivation differs among these genes, with c-fos being 
the earlist detectable (within 5 minutes), followed by c-myc (1-2 hours). Other proto-
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oncogenes are induced as much as 6 hours later. These observations and the ample 
evidence implicating c-fos and c-myc in the control of cell proliferation led to a focused 
attention on these two genes. Whereas PDGF, fibroblast growth factor (FGF) and PMA 
induce c-myc in all cell types, the effect of EGF is strain-dependent for mouse fibroblasts 
(Muller et al., 1984). PDGF is also a much more potent inducer of c-fos than EGF 
(Muller et al., 1984), and insulin is not effective at all. However, both EGF and insulin 
induce c-fos transcripts in cells bearing high numbers of the corresponding receptor, 
suggesting that c-myc and c-fos are not strictly "competence" genes whose expression 
is required for leading cells from the quiescent state (GO) to competent state (Gl) in 
which cells are considered to respond to the continuous action of progression factors and 
enter the S phase (DNA synthesis) (Pledger et al., 1977; Stiles, 1985). 
Expression of c-fos and c-myc is correlated with growth stimulation in several 
respects. For example, c-myc mRNA is induced by agents that initiate the proliferation 
of quiescent cells (Kelly et al., 1983). Microinjection of c-myc protein into the nuclei 
of Swiss 3T3 cells stimulated DNA synthesis in cells (Kaczmarek et al., 1985). 
BALB/c-3T3 cells transfected with c-myc recombinant plasmids responded mitogenically 
to EGF and insulin in the absence of PDGF (Armelin et al., 1984). Levels of c-fos 
mRNA are higher in growing cells than in quiescent cells (Muller et al., 1984) and 
increase during liver regeneration at a time corresponding to peak thymidine 
incorporation (Corral et al., 1985). The correlation between c-fos expression and 
mitogenesis suggested by these findings is strongly supported by the data demonstrating 
reduced proliferative activity in BALB/c-3T3 cells transfected with an antisense c-fos 
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RNA (Holt et al., 1986). 
Multiple signal transduction pathways regulate the expression of these early genes 
(Chiarugi et al., 1987; Nigg, 1990; Rozengurt and Sinnett-Smith, 1988). Activation of 
the PKC pathway induces both c-fos and c-myc, whereas agents that elevate cyclic AMP 
preferentially stimulate the expression of c-myc in Swiss 3T3 cells (Rozengurt and Ober, 
1990). Colony stimulating factor-I (CSF-1) induces both c-fos and c-myc in 
macrophages (Muller et al., 1985), with an unusual biphasic induction response for c-fos. 
The later more stable phase was attributed to a mechanism that involves protein kinase 
A (Nigg, 1990). On the other hand, the early transient phase common to other mitogens 
is mediated by both a PKC-dependent pathway as well as other mechanisms (Chiarugi 
et al., 1987) which involve Ca2+ ion (Sheng et al., 1990) and possibly cyclic AMP 
(Nigg, 1990). 
Polyamines and Omithine Decarboxylase 
Putrescine, spermidine and spermine, collectively known as the polyamines, are 
essential for the life of all eukaryotic cells, since mutants lacking the ability to synthesize 
them die unless the polyamine are provided in cell culture medium (Canellakis et al., 
1989). These metabolically related polyamines carry a positive charge at a physiological 
pH and are the most abundant endogenously produced cations, but this important function 
does not explain their essential role in cell survival. These low molecular weight, 
aliphatic amines have been shown to be elevated in association with increased cellular 
activity and to be implicated in a wide range of diverse cell functions (Janne et al., 
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1991). Putrescine, the parent diamine, arise intracellularly by decarboxylation of the 
amino acid omithine by the enzyme omithine decarboxylase (ODC). Spermidine and 
spermine are formed from putrescine by the sequential addition of two aminopropyl 
moieties derived from methionine. Putrescine, spermidine and spermine are collectively 
referred to as the parent polyamines. Both acetylated and oxidized forms of these 
compounds are known to occur naturally. 
In spite of their highly conserved and essential nature, the exact physiological 
functions of the polyamines are not clear. In addition to their role as intracellular 
cations, they are known to modulate the conformation and transcription of DNA (at least 
in vitro) and to participate in the post-translational modification of proteins (Canellakis 
et al., 1989). Neverthless, the involvement of polyamines in the cell growth has become 
evident (Janne et al., 1991). 
ODC, which has a turnover rate amongst the fastest of any known mammalian 
enzymes, is subject to a number of influences that increase its activity, including growth 
promoters or trophic influences, such as serum, growth factors and hormone (Tabor and 
Tabor, 1984). The increased activity of ODC is always associated with a rapid rise in 
cellular proliferation. Furthermore, the use of a-difluoromethylomithine (DMFO), a 
specific and irreversible inhibitor of ODC, has been shown to abolish completely the 
growth factor-induced increased ODC activation as well as cell proliferation (Arlow et 
al., 1990). Transformed cells usually have elevated baseline ODC activities(Chang, 
1991). Expression of ODC becomes constutively activated during cell transformation 
induced by carcinogens (Arlow et al., 1989), viruses (Auvinen et al., 1992) or oncogenes 
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(Auvinen et al., 1992). In general, influences that cause rapid increased ODC activity 
do so by enhanced transcription and protein synthesis (Porter and Bergeron, 1988). Ca2+ 
ion has been shown to a requirement for the serum-mediated increased synthesis of ODC 
enzyme (Chang, 1991; Ginty and Siedel, 1989). Synthesis of ODC also proved to be 
increased by the pathways involving PKC or cyclic AMP (Canellakis et al., 1989). 
C. Role of Calcium in Cell Proliferation 
Regulation of Intracellular Calcium 
A low [Ca2+]i ( = 10-1 M) is maintained by a complex interaction of several 
biochemical precesses. These include the regulation of plasma membrane Ca2+ channel 
opening, the binding of Ca2+ to membrane surfaces and Ca2+ -binding proteins, the 
extrusion of Ca2+ from the cytosol either out of the cell across the plasma membrane or 
into multiple, intracellular storage sites and the regulation of release of Ca2+ from these 
intracellular compartments. In different cell types the Ca2+i can be regulated via different 
combinations of these regulatory pathways (Reviewed in Carafoli, 1987; Rasmussen and 
Rasmussen, 1990; Villereal and Byron, 1992). 
a) Calcium Channels 
Since the Ca2+ concentration is 1Q4 times higher outside the cell than in the cytosol, 
and since Ca2+ would move down an electrical gradient, the "opening" of the plasma 
membrane Ca2+ channels, even transiently, is a very effective mechanism for elevating 
intracellular Ca2+ concentration, as well as for depolarizing the cell. Depending on the 
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cell type, several mechanisms are involved in opening Ca2+ channels. 
Excitable cells have voltage-sensitive Ca2+ channels (VSCCs) which open in response 
to a membrane depolarization. Based on biophysical and pharmacological criteria, the 
VSCCs have been characterized as either T, N or L types (Kostyuk, 1989; Bertolino, 
1992). Recent studies suggest that VSCCs exist in nonexcitable cells, such as fibroblasts 
(Olsen et al., 1989) and glial cells (Barres et al., 1990). 
In addition to VSCCs, Ca2+ channels appear to be directly associated with membrane 
receptor proteins. The best example of a ligand-sensitive Ca2+ channel is the N-methyl-
D-aspartate (NMDA) type of glutamate receptor, which appears to gate an ion channel 
that is highly permeable to Ca2+ as well as Na+ and K+ (McDonald and Johnston, 1990). 
b) Release from Intracellular Calcium Stores 
In many cells the response to hormone stimulation is mediated by a release of Ca2+ 
from intracellular stores. Berridge and coworkers first described a new pool of 
phosphatidylinositol (i.e. PIPi), which, when acted on by PLC, could release IP3 and 
DAG (Berridge and Irvine, 1984). This work suggested that IP3 could serve as a type of 
second messenger. Subsequent studies in numorous other cell types have confirmed that 
the release of IP3 leads to the mobilization of Ca2 \ in response to many hormones 
(Berridge, 1993; Berridge and Irvine, 1984; Fisher et al, 1992; Renzi and MacDermott, 
1992; Michell, 1992; Villereal and Byron, 1992). 
Recently, a more highly phosphorylated metabolite of inositol, e.g. (l,3,4,5)IP4, is 
known to be produced when (1,4,5)1P3 was phosphorylated by a (l,4,5)IP3 kinase (Fisher 
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et al., 1992). Current speculation is that IP4 may be involved in regulation of Ca2+ 
influx channels. This hypothesis arises from the observation that IP4 microinjection into 
sea urchin eggs caused the immediate elevation of the fertilization envelop for eggs in 
the presence, but not in absence, of external Ca2+ (Irvine and Moore, 1986). The 
synergism between the Ca2+ mobilizing agent IP3 and IP4 has been speculated to be 
related to an effect of IP4 on the reloading of IP3-sensitive Ca2+ compartment via Ca2+ 
influx across the plasma membrane. In addition, an apparent positive feedback 
regulatory mechanism exist in which Ca2+ influx stimulates IP4 production and IP4 
stimulates Ca2+ influx (DeLiscle et al., 1992). Moreover, for cells in whole cell-
perfusion via patch clamp methods, both IP3 and IP4 are necessary for Ca2+ -activated K+ 
currents (Morris et al., 1987). 
The observation that (1,4,5)IP3 mobilizes Ca2+ from intracellular stores whereas very 
similar inositol phosphates do not, argues for a high degree of specificity in the 
mechanism for Ca2+ release. This observation suggests the existance of specific 
receptors that recognize (l,4,5)IP3 on the surface of Ca2+ store vesicles (Ferri and 
Snyder, 1992; Taylor and Marshall, 1992). Using binding of 3H-IP3, the IP3 receptor-
channel complex was solubilized and purified to apparent homogeneity from rat 
cerebellum (Maeda et al., 1991). The IP3 receptor is a very large homotetrameric 
protein with sequences near the carboxyl termini which are thought to form membrane-
spanning helices that together comprise the Ca2+ channel (Ferris and Snyder, 1992). 
Opening of the channel is regulated largely by ligand binding to the large cytoplasmic 
amino termini of the receptors, which evokes a substantial conformational change in the 
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receptor and ultimately leads to channel opening (Taylor and Marshall, 1992). 
c) Extru.sion Calcium from the Cytopla.sm 
To maintain the resting [Ca2+1i at 100 nM, the cell must actively extrude Ca2+ from 
the cytoplasm. This Ca2+ is both extruded across the plasma membrane and sequestered 
into the intracellular Ca2+ compartments, from which it can be released upon receptor 
activation. The two major transport systems for moving Ca2+ are the Ca2+ -ATPase and 
the Na+/ca2+ exchanger. The Ca2+ -ATPase system couples the energy released in the 
hydrolysis of ATP to the movement of Ca2+ against large concentration gradients; the 
Na+/ca2+ exchanger utilizes the energy stored in the Na+ electrochemical gradient to 
move Ca2+ against a concentration gradient. Two distinct types of Ca2+ -ATPases exist: 
one present in the plasma membrane and the other present in the structures that sequester 
intracellular Ca2+ (Reviewed in Carafoli, 1987; Rasmussen and Rasmussen, 1990). 
Effector Systems Regula.ted by lntracellula.r Calcium 
The physiological effects of Ca2+ are mediated by a multiplicity of Ca2+ -binding 
proteins. In a few cases the binding protein is closely linked to or is a part of the 
effector molecule, e.g. this appears to be the case with Ca2+-activated K+ channels. In 
many other instances the Ca2+ -binding protein has no biological activity of its own but 
must interact with other proteins to produce the final physiological effect. Thus, Ca2+ -
binding proteins can be thought of as "third messengers" of the original extracellular 
signal (Reviewed in Villereal and Palfrey, 1989). 
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Calmodulin is one of the most important and best-characterized Ca2+ -binding proteins 
which include troponin C, calsequestrin, spasmoneme, colenterate photoproteins and 
parvalbumin. Calmodulin is a highly conserved, acidic, 16. 7-kd protein that is 
ubiquitous in eukaryotic cells. The cytoplasmic concentration of calmodulin lies between 
2 and 30 µM in various mammalian tissues, making it an important Ca2 \ buffer. 
Calmodulin has four binding sites for Ca2+ (two of high affinity and two of lower 
affinity) and two low-affinity metal-binding sites. The binding of each Ca2+ ion leads 
to stepwise conformational changes (the largest being with the binding of the third Ca2+) 
that result in the exposure of hydrophobic domains in the protein. These domains are 
thought to contribute to the interaction of calmodulin with various calmodulin-binding 
proteins and calmodulin antagonists such as trifluoperazine (Reviewed in Hait and 
DeRosa, 1988; Manalan and Klee, 1984). 
The final effectors of many Ca2+ -regulated processes are the numerous calmodulin-
binding proteins. The best studied of these proteins can be loosely grouped into four 
classes (Villereal and Palfrey, 1989): (i) protein kinases and phosphatases, (ii) 
phosphodiesterases and adenylate cyclases, (iii) cytoskeletal proteins and (iv) Ca2+ -
ATPases. In an intact cell the effects of calmodulin are modulated not only by the 
affinity but also by the abundance of various calmodulin-binding proteins. This implies 
that differences in the kinetics and degree of occupancy of different calmodulin receptors 
will exist during the Ca2+ response (Villereal and Palfrey, 1989). 
25 
Role of Calcium in Nonna[ Cell Proliferation 
Increased free Ca2+ i concentration stimulated by growth factors are thought to play 
a key role in the initiation of a series of events that ultimately lead to cell proliferation 
(Reviewed in Villereal and Byron, 1992). Evidence for such a role of Ca2+ in growth 
factors action comes from the numorous findings: PDGF caused a transient rapid 
increased Ca2+i concentration in human fibroblasts (Moolenaar et al., 1984), vascular 
smooth muscle cells (Roe et al., 1989) and BALB/c-3T3 cells (Zagari et al., 1989). 
Insulin-like growth factor II (IGF-11) also increased free Ca2\ in BALB/c-3T3 cells 
(Nishimoto et al., 1987) as well as do various mitogens in human endothelial cells (Jacob 
et al. , 1988), human fibroblasts (Peres et al., 1990), glomerular mesangial cells 
(Bonventre et al., 1986), thyroid cells (Takada et al., 1990), Swiss 3T3 cells (Takuwa 
et al., 1991) and lymphocytes (Henry-Toulme et al., 1990). 
The importance of increased intracellular Ca2+ concentration in cell proliferation has 
been suggested from numorous studies which have used pharmacological agents to block 
growth factor-induced increased Ca2+i or used low amounts of Ca2+ in the culture 
medium. These studies also resulted in inhibition of growth factor-stimulated mitogenesis 
(Batra et al., 1991; Block et al., 1989; Cahalan and Lewis, 1990; Ogata et al., 1991; 
Olsen et al., 1989; Roe et al., 1989; Shultz and Raij, 1990; Tucker et al., 1989; Zagari 
et al., 1989). Thus, in normal cell proliferation the increased Ca2+i appears to result 
from the influx of Caz+ and the blockade of this source can apparently inhibit cell 
proliferation. Moreover, some electrophysiological studies showed that growth factors 
induce the activation of unusual, voltage-independent, Ca2+ permeable channels (A vdonin 
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et al., 1991; Kuno et al., 1986; Peppelenbosch et al., 1992; Puro, 1991; Puro and 
Mano, 1991; Zschauer et al., 1988). 
Although these findings are suggestive, the major difficulty involved in establishing 
a direct cause-and-effect relationship between growth factor-induced alterations of Ca2+i 
and DNA synthesis arises from the lengthy period of time (24-36 hr) separating these two 
different phenomena. However, recent, notable reports demonstrated the requirement 
of early PDGF-stimulated alterations in Ca2+i in mitogenesis in two different PDGF-
growth-dependent cellular systems, e.g. BALB/c-3T3 fibroblasts and porcine vascular 
smooth muscle cells (Diliberto et al. , 1991). The presence of pharmacological agents 
at a time after PDGF stimulation, is neither toxic nor inhibitory to subsequent cellular 
DNA synthesis, while these agents did, indeed, prevent alterations in Ca2+i· The critical 
time period for Ca2+i alterations in PDGF-induced mitogenesis has, thus, been narrowed 
down to the first few hours following growth factor exposure. 
In serving as a Ca2+ receptor protein, calmodulin (CaM) appears to be critically 
involved in the regulation of mammalian cell proliferation, particularly at the G 1/S 
boundary (Rasmussen and Means, 1988). CaM has also been implicated in growth 
factor-dependent proliferation of human hematopoietic progenitor cells, and the cell 
proliferation is highly sensitive to CaM antagonists (Katayama et al., 1990). CaM levels 
are elevated two- to threefold during late G 1 period, and a direct correlation was 
observed between intracellular CaM levels and the ability of mammalian cells to replicate 
DNA (Chafouleas et al., 1982; Gruver et al., 1992). Furthermore, the stimulatory effect 
of ca2+ on DNA synthesis is blocked by CaM antagonists or antibody (Jones et al., 
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1982). Although the exact mechanism of action of CaM in inducing cell growth remains 
obscure, some studies regarding to that issue have been reported. Proliferative 
stimulation of rat liver cells is observed to be accomplished by the nuclear rearrangement 
of CaM. by its association with the nuclear matrix (Serratose et al., 1988). Specific 
CaM-binding proteins are found to be associated with DNA polymerase-a from a variety 
of mammalian cells (Hammond et al., 1988) and with the multienzyme complex 
responsible for nuclear DNA replication in fibroblast cells (Subramanyam et al., 1990). 
In addition, the nuclear localization of the 68-Kd CaM binding protein in Chinese 
hamster fibroblast cells is dependent on the induction of cell proliferation in these cells 
by exposure to insulin (Subramanyam et al., 1990). These observations suggest that the 
induction and/or nuclear localization of specific CaM binding protein(s) may control a 
terminal event required for the onset of DNA replication and, therefore, for cell 
proliferation (Reddy et al., 1992). 
Calcium Messenger Systems in Tumor Cell Proliferation 
Neoplastic transformation may be accompanied by various structural and behavioral 
changes in cultivated cells: (i) acquisition of unlimited growth and proliferative potential; 
(ii) production of plasminogen activator; (iii) loss of density-dependent inhibition of cell 
movement and proliferation; (iv) dispersal of the cytoskeleton of actin-containing 
microtubules (v) loss of a large surface glycoprotein; (vi) reduction of the serum 
requirement for proliferation (Reviewed in Calarkson and Baserga, 1974; Hynes, 1976; 
Poten, 1971). Neoplastic transformation of a wide variety of avian, human and rodent 
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cells of mesenchymal origin by chemicals (methyl-cholanthrene and nickel sulfide), 
viruses (adenoviruses, SV 40, and the Kirsten and Rous sarcoma viruses) and multiple 
passages in vitro, also eliminates or at least very greatly reduces the extracellular free 
Ca2+ requirement for the initiation of a later phase of prereplicative (Gl) development 
(Balk et al., 1973; Whitfield, 1990). 
Since Ca2+ and CaM appear to play a critical role in normal cellular proliferation, 
alterations in this Ca2+ messenger system may occur in and be responsible for states of 
abnormal cellular proliferation in the cancer development. 
This limb of the Ca2+ messenger could be possibly altered at six general sites: (i) the 
interaction of extracellular ligands with their receptors; (ii) the signal transduction 
between receptors and phospholipase C; (iii) the sensitivity of phospholipase C to 
activators; (iv) the release of of Ca2+i through the interaction of IP3 with Ca2+ -storage 
sites; (v) the quantity or structure of calmodulin resulting in alterations in its sensitivity 
to Ca2+ and/or its interaction with target proteins; (vi) changes in calmodulin-binding 
proteins. 
Several tumors are known to produce autocrine growth factors such as bombesin, 
PDGF and EGF which activate PLC through interaction with specific membrane 
receptors (Heldin et al., 1987; Herlyn et al., 1990; Herlyn and Malkowicz, 1991; Lang 
and Burgess, 1990). Thus, a fundamental step in initiation or propagation of malignancy 
might occur at the receptor-ligand locus. 
Overexpression or altered expression of the growth factor receptors has been reported 
a variety of human carcinoma (Radinsky, 1991). For example, increased expression of 
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EGF receptor has been observed on metastatic human colon and renal carcinoma cells 
(Radinsky, 1991). The v-erb B oncogene of avian erythroblastosis virus encodes a 
truncated version of EGF receptor, which lacks the EGF-binding domain but contains a 
continuously-active tyrosine kinase domain which is required for the activation of PLC--y 
(Heldin et al., 1987). 
P21, the transforming protein encoded by the ras oncogene of the Kirsten and 
Harvey sarcoma viruses, resembles G proteins in its ability to bind GTP. Expression of 
this oncogene product in transformed cells has been shown to result in an exaggerated 
turnover of phosphoinositides in response to autocrine growth factors (Cantley et al. , 
1991). Therefore, PLC can indirectly be sensitized to activation by oncogene products 
such as P21. PLC could also possibly be directly altered during malignant 
transformation. 
Changes in Ca2+i due to altered responsiveness to IP3 have not been reported. 
However, differences in the intracellular concentration of Ca2+ between normal and 
malignant cells have been observed. For example, an increased free Ca2+i concentration 
was found in malignant compared with normal cells (Viegl et al., 1982). Hickie and 
Kalant found a direct correlationship between the rate of growth of Morris hepatomas and 
their intracellular Ca2+ concentration (Hickie and Kalant, 1967). 
3T3 cells transformed by Rous sarcoma virus and normal rat kidney cells 
transformed by SV-40 virus demonstrated concentrations of calmodulin two to three times 
greater than those of untransformed cells (Criss and Kakiuchi, 1982). Qualitative 
changes in calmodulin have also been observed. For example, Isobe et al. purified from 
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porcine brain des-(alanine-lysine) calmodulin, a molecule that lacks alanine and lysine 
residues at positions 147 and 148, respectively (Isobe et al., 1981). Qualitative 
abnormalities in calmodulin could alter its interaction with target proteins. For example, 
the biological activity of calmodulin based on the ability of the extractable calmodulin 
to activate a sensitive cyclic nucleotide phosphodiesterase were markedly increased in 
malignant tissue (Hait, 1987). Moreover, oncomodulin, a tumor-specific, calmodulin-like 
protein has been isolated from neoplastic cells (MacMaus et al., 1984). Compared to 
calmodulin, oncomodulin is smaller (108 amino acids), more acidic and its spectrum of 
activity less broad than calmodulin. 
Qualitative or quantitative changes could also occur in CaM-binding proteins. These 
changes might result in abnormal interaction between CaM and its target proteins, 
causing a selective increase or decrease in calcium-CaM-dependent processes. For 
example, differences in CaM-binding proteins have been found in rat kidney fibroblasts 
(NKK LA-23) transformed by a temperature-sensitive mutant of the Rous sarcoma virus 
or rat kidney cells (6M2) transformed by a temperature-sensitive mutant of the Moloney 
sarcoma virus (Connor et al., 1983). 
A. Cell Culture 
Cell Line Characteristics 
CHAPTER ill 
MATERIALS AND METHODS 
a) U-373 MG human astrocytoma 
Cultures of these cells were established by B. Westermark as explants which 
originated from 61-year old Caucasian male who had blood type-A+ (Poten et al., 1968). 
These cells have epithelial-like morphology. In addition, these cells have glial fibrillary 
acidic protein (GFAP), indicative of astrocytes, produce fibronectin and were tumorigenic 
in nude mice (Bigner et al., 1981; Jones et al., 1981). Some studies showed that these 
cells have functional substance-P receptors (Lee et al., 1989). Trypsinization of the 
outgrowth or cells attached to the vessel floor with subsequent transfer to a growth 
medium permitted the cell line development. This cell line has been used very often in 
the studies of immunological characterization of glial cell origin (Boeckh et al., 1991; 
Murphy and Hart, 1992). The cells (passage no. 181) were purchased in May of 1991 
from American Type Culture Collection (Rockville, MA). 
b) SK-N-MC human neuroblastoma 
In 1971 this cell line was derived by J.L. Biedler and is of neurogenic origin from 
a 14-year old Caucasian female who had blood type-a+ (Spengler et al., 1973). The cells 
have an epithelial-like morphology. The cells showed tumorigenicity in nude mice and 
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in the hamster cheek pouch. The cell line was found to have moderate dopamine-{3-
hydroxylase activity as well as formaldehyde-induced fluorescence indicative of 
intracellular catecholamines (Spengler et al., 1973). NPY neurotransmitter was shown 
to bind to this cell line and induced intracellular Ca2+ mobilization (Michel et al., 1992). 
This cell line was also used in the study of the signal transduction mechanism of 
neurotransmitters (Feth et al., 1991; Hiley et al., 1992). The cells (passage no. 41) 
were purchased in October of 1991 from ATCC (Rockville, MA). 
Cell Growth 
a) Culture Medium 
Eagle's minimum essential medium (MEM) (Sigma, St. Lous, MO) was used as a 
culture medium for the cell growth. The components (g/L) are: L-alanine, 0.0089; L-
arginine.HCl, 0.126; L-asparagine.H20, 0.015; L-aspartic acid, 0.0133; L-cystine.2HC1, 
0.0133; L-glutamic acid, 0.0147; L-glutamine, 0.292; glycine, 0.0075; L-
histidine.HC1.H20, 0.042; L-isoleucine, 0.052; L-leucine, 0.052; L-lysine.HCl, 0.0725; 
L-methionine, 0.015; L-phenylalanine, 0.032; L-proline, 0.0115; L-serine, 0.0105; L-
thereonine, 0.048; L-tryptophan, 0.010; L-tyrosine.2Na, 0.0519; L-valine, 0.046; 
choline chloride, 0.001; folic acid, 0.001; myo-inositol, 0.002; niacinamide, 0.001; D-
pantothenic acid.Ca, 0.001; pyridoxal.HCl, 0.001; riboflavin, 0.0001; thiamine.HCl, 
0.001; calcium chloride.2H20, 0.265; magnesium sulfate (anhydrous), 0.09767; 
potassium chloride, 0.400; sodium chloride, 6.800; sodium phosphate monobasic 
(anhydrous), 0.122; D-glucose, 1.000; phenol red.Na, 0.011. For washing the cells, 
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Earle's basal salt solution (EBSS) (Sigma, St. Lous, MO) was used. The components 
are the same as those of MEM without amino acids and vitamines. MEM or EBSS 
powders were dissolved in the sterilized water by gentle stirring. Supplements (i.e. 110 
mg/L of sodium pyruvate (Sigma, St. Lous, MO) and 2.2 g/L of sodium bicarbonate 
(Sigma, St. Lous, MO)) were added prior to filtration. While stirring, the pH of the 
solution was adjusted by 1 N NaOH to 0.2 pH units below the desired pH (i.e. 7.4) since 
the pH usually goes up during filtration. The solution was sterilized immediately by 
filtration using a membrane with a porosity of 0.2 microns. The filtered medium was 
aseptically dispensed into sterile containers. The sterility of the medium was checked by 
overnight incubation of a few milliliters of the solution at 37°C. After checking for signs 
of contamination, fetal bovine serum (FBS) and antibiotics (penicilline and streptomycin 
mixtures) were added to the medium. The sterility of this final solution was also 
checked. All media and salt solutions were stored in a refrigerator at 4°C. 
b) Initial Culture 
Both astrocytoma and neuroblastoma cell lines were shipped in frozen medium 
containing DMSO. These were initiated culture as soon as possible upon receipt. The 
cells in a small ampule (volume: 1.0 ml) were thawed by rapid agitation in 37°C water 
bath. The cells were diluted in serum-containing culture medium and centrifuged at 300 
x g for 15 minutes in order to remove DMSO. The cell pellet was resuspended in 
culture medium and transferred to 75 cm2 tissue culture flask. Cells were grown at 37°C 
in a humidified incubator under 5% COi/95% air in an Eagle's minimum essential 
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medium (MEM) supplemented with 10% fetal bovine serum (FBS) (Gibco BRL, Grand 
Island, NY), 200 IU/ml of penicilline, 200 µg/ml of streptomycin (Gibco BRL, Grand 
Island, NY) and 1 mM sodium pyruvate. 
c) Cukure Maintainance 
Culture medium was replaced twice weekly. After attaining confluency, the cells 
were subcultured. The old medium was removed and the cells were washed twice with 
fresh Eagle's basal salt solution (EBSS) . The cells were harvested by adding 0.25% 
trypsin (Sigma, St. Lous, MO) for 5 minutes. Serum-containing MEM was added and 
triturated well by suction in and out through pipette in order to break up large cell 
clumps. The cells were centrifuged at 300 x g for 15 minutes in order to prevent cell 
membrane damage possibly induced by residual trypsin. The cells were seeded at 1 :5 
(astrocytoma cell line) and 1: 10 (neuroblastoma cell line) dilution into new 75 cm2 flasks 
(Falcon, England). 
B. Cell Growth and Cell Cytotoxicity Assay 
Cell Growth Assay 
a) Initial Seeding 
Cells from four to five-day-old cultures were seeded in equivalent amounts in 35 x 
10 mm culture dishes (Fisher Scientific, Pittsburgh, PA) at the density of 10' and 2x10' 
cells/dish in neuroblastoma and astrocytoma cell lines, respectively. The volume of the 
medium in the dishes was 2 ml. Since the equivalence of the initial cell density is quite 
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important in cell growth assay, the clumps of cells were isolated into single cells by first 
trituration and, if necessary, passing through a 20 gauge needle. Particularly, the 
astrocytoma cell line was very resistant to the treatment of trypsin and, thus, needed 
more vigorous handling. However, this procedure did not affect the viability of cells 
as assessed by the trypan blue exclusion method. 
b) Drug Treatment 
After one day culture for the attachment of the cells, the cells were grown for two 
more days with or without various drugs. Ca2+ channel modulators such as verapamil, 
nifedipine, diltiazem and Bay K-8644 were used and purchased from ICN Chemicals 
(Cleveland, OH). As K+ channel modulators tetraethylammonium chloride (TEA), 4-
aminopyridine (4-AP) and diazoxide were used, and all were obtained from Sigma (St. 
Louis, MO). A receptor-operated calcium channel antagonist, SK&F 96365 was used 
and generously supplied by Dr. Hills from Smith Kline Beecham Pharmaceuticals 
(Welwyn, Hertfordshire AL6 9AR, England). Tetradotoxin, a Na+ channel antagonist, 
and veratridine, a Na+ ionophore, were also used and obtained from Sigma. Cobalt 
chloride, nickel chloride, ethylene glycol-bis (/j-aminoethyl ether) N,N,N' ,N'-tetraacetic 
acid (EGTA), methionine enkephalin and angiotensin II were also used, and all the drugs 
were obtained from Sigma. Concentrated stock solutions of the drugs were added 
directly to the culture dishes. The volume of the drug solutions did not exceed 20 µl. 
Water-insoluble drugs were solubilized in ethanol, and the volume of these drug solutions 
was limited to 10 µl in order to prevent the effect of ethanol itself. In fact, this 
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concentration, 0.5% of ethanol did not affect cell growth significantly. Drugs and 
culture medium were replaced every day. 
c) Cell Counting 
Assessment of cell growth was made by counting the number of cells using a 
hemocytometer (Fisher Scientific, Pittsburg, PA). After three day culture the old 
medium was removed by aspiration and the cells were washed twice using EBSS. The 
cells were detached from the bottom of the dishes by incubation with 0.25% trypsin. 
200 µl of the trypsin solution was added to each dish. After complete detachment 1 
ml of serum-containing MEM was added to each dish and transferred to a 12 x 75 mm 
test tubes (Baxter, McGaw, IL) by using a syringe attached to a 20 gauge needle (Becton 
Dickinson, Rutherford, NJ). The neuroblastoma cells were easily isolated into a single 
or countable small clumps of cells (less than 3 cells) by only this procedure. However, 
in the case of astrocytoma cells, a few more passing through the neddle was needed for 
breaking the clumps of cells. The cell suspension was usually further diluted twice or 
three times using EBSS, depending upon final cell density. Practically, one hundred cells 
per 1 mm square of the hemocytometer are desirable cell density. With the cover-slip 
in place, a small amount of cell suspension was transferred to both chambers of the 
hemocytometer using a Pasteur pipette (Baxter, McGaw, IL) by carefully touching the 
edge of the cover:-slip with the pipette tip, which allowed each chamber to fill by 
capillary action. In that procedure overfilling or underfilling of the chambers were 
prohibited. Starting with chamber 1 of the hemocytometer, the cells were counted in 
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four 1 mm comer squares. The cells on top and left touching middle line of the 
perimeter of each square were counted, but the cells touching the middle line at bottom 
and right sides were not counted. This procedure was repeated for chamber 2. Each 
square of the hemocytometer, with cover-slip in place, represents a total volume of 0.1 
mm3 or 104 ml. The subsequent cell concentration per 1 ml (and the total number of 
cells) could be determined using the following calculations: 
Cells per ml = the average count per square x 1()4 
Total Cells = cells per ml x the original volume of fluid (ml) 
The effects of the various drugs on the cell growth were observed as % of control 
condition in comparison with the number of cells using the following calculation: 
% of Control = [total cells (drug-treated)/total cells (control)] x 100 
d) Effect of Carbachol on Astrocytoma Cell Growth 
In order to observe the effect of carbachol on astrocytoma cell growth, initial seeding 
procedure was the same as previously described. After one day culture in which 10% 
FBS was used, the cells were washed twice using EBSS for removing residual serum. 
For further cultures, 0.1 % FBS-containg medium was used. This very low serum 
concentration prevented cell death but did not induce significant cell proliferation. 10 
µl of the stock solutions of carbachol (Sigma, St. Louis, MO) dissolved in MEM were 
added at the desired concentrations. Cell counting was done as previously described. 
The effect of carbachol on the cell growth was shown as % of control condition in 
comparison with the number of cells using the same calculation as that in the case of 
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other drugs. 
Cell Cytotoxicity Assay 
Cell cytotoxicity was assayed by trypan blue exclusion method in order to observe 
the effect of drugs on cell viability. This method is based on the principle that live cells 
do not take up the dye, whereas dead cells do. Initial seeding and drug treatment were 
done by the same procedure as that of cell growth assay. However, after drug treatment, 
the medium and drugs were not replaced during subsequent 2 days cultures. The old 
medium was carefully collected in a 12 x 75 mm test tube (Baxter, McGaw, IL) using 
polyethylene transfer pipettes (Fisher Scientific, Pittsburgh, PA). The cells were washed 
twice and washing fluids were also collected. Remaining attached cells were harvested 
using 0.25 % trypsin and also collected in the test tube. After mixing up well, the cell 
suspension was centrifuged at 300 x g for 15 minutes. Cell pellets were resuspended in 
1 ml of EBSS, and 0.5 ml of trypan blue (0.4%) (Sigma, St. Louis, MO) was added. 
This solution was throughly mixed and was allowed to stand for 15 minutes. However, 
the cells were prohibited from prolong exposure to trypan blue because viable cells may 
begin to take up dye in this condition. The cells were counted by the same method 
which used in cell growth assay. With the only difference being that viable (unstained) 
and non-viable (stained) cells were separately counted. % cell death was determined 
using the following calculations: 
% Cell Death = [total dead cells (stained)/total cells (stained + unstained)] x 100 
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Data Analysis 
For dose-response curves, at least four different experiments were done. The 
number of cells in a dish was derived from averaging the four different counts. All the 
data were displayed as % of control condition in comparison with the number of cells. 
Data were expressed as mean ± standard error of the mean (SEM). The data were 
analyzed using one way analysis of variance (ANOVA) and Student-Newman-Keul's test 
for follow-up test. The data which have p value less than 0.05, were considered to be 
statistically significant. Plotting dose-response curves and bar graphs was made using 
the Sigma Plot program. 
C. Measurement of Intracellular Calcium Concentration 
Solutions 
a) Fura-2-AM 
The AM (acetoxymethyl) ester derivative of fluorescent indicator (i.e. Fura-2) 
(Molecular Probes, Eugene, OR) was used in this study. Modification of carboxylic acid 
with an AM ester group results in an uncharged molecule which can permeate cell 
membranes. Once inside, the lipophilic blocking groups are cleaved by nonspecific 
esterase activity in the cell resulting in a charged, free acid form which leaks out of cells 
far more slowly than its parent compound. Hydrolysis of the esterified group is essential 
for binding of the target ion (i.e. Ca2+ ion). Since the AM esters are relatively insoluble 
in aqueous solutions, the low toxicity dispersing agent, pluronic acid was used. This 
nonionic detergent was dissolved in DMSO (Sigma, St. Louis, MO) at the final 
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concentration of 20% (w/v) by keeping in 37°C waterbath for 20 minutes, and this 
solution was used to make up the dye stock. This DMSO stock solution was stored at 
room temperature since refrigeration may result in separation of pluronic acid. The 
DMSO stock solution was added to a small vial which contains 50 µg of Fura-2-AM 
(M. W. 1000) and vortexed for 15 minutes before making a 200 µM Fura-2-AM stock 
solution. This stock solution was aliquoted out to 50 µl of solution and kept in vials 
covered with aluminum foil and stored in the freezer (- 700C). Since the stability of AM 
ester of the dye may decrease in this condition, the stock solution was used as soon as 
possible (within a few days after being made). 
b) Krebs-Ringer Buffer (KRB) 
For washing and resuspending cells KRB solution was used. This solution contains 
125mM NaCl, 5mM KCl (Mallinckrodt, Paris, KE), l.2mM KH2P04 , l.2mM MgS04 , 
5mM NaHC03, l.3mM CaC12 (Mallinckrodt, Paris, KE), 25mM HEPES and 6mM 
glucose. All salt powders were obtained from Sigma unless otherwise noted. The pH 
was adjusted to 7.4 with 1 N NaOH. Ca2+ -free KRB was made by just omitting CaC12 
in the solution. 
c) Triton X-100 
0.1 % solution of Triton X-100 (Sigma, St. Louis, MO) was made by dissolving it 
in KRB solution. 
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d) EGTA Solution 
60mM EGTA solution was made by dissolving it in the solution of Tris base, at pH 
8.2. 
Procedure 
a) Preparation of Aliquot of Tumor Cells 
Tumor cells at about 70% confluency were harvested by trysinization (trypsin 
concentration, 0.25 and 0.5% for neuroblastoma and astrocytoma cells, respectively). 
The cells were diluted in MEM solution and centrifuged at 400 x g for 5 minutes for 
removing residual trypsin. The pellet of the cells was resuspended in KRB solution at 
a density of 5xle>6 cells/ml. The cell suspension was transferred to a 16 x 125 mm test 
tube. 
b) Loading Fura-2-AM 
Fura-2-AM stock was added to the cell suspension at the final concentration of 2µM. 
In general, the concentration of the dye should be kept as low as possible to reduce 
potential artifacts from overloading including incomplete hydrolysis, 
compartmentalization and toxic effects from hydrolysis by-products such as 
formaldehyde. The test tubes containing the cell suspension and the dye were covered 
with aluminum foil during incubation time to prevent exposure of light. The cells were 
incubated for 60 minutes at room temperature in an incubator which alternatively moving 
at a speed of 120 rpm since some investigators have reported greater degrees of 
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compartmentalization at physiological temperatures than at room temperature. 
c) Removing Unloaded Fura-2-AM 
After incubation the cells were diluted ten times using KRB solution (Ca2+ -containing 
or Ca2+ -free, depending on the protocol) and centrifuged at 400 x g for 5 minutes. The 
pellet of the cells was resuspended in KRB solution. For neuroblastoma cells before 
second washing, the resuspended cells were allowed to sit for more than 20 minutes. 
This procedure allowed complete hydrolysis by nonspecific esterases of the loaded Fura-
2-AM into the free acid form which does not readily leak out of cells. However, in the 
astrocytoma cells this additional incubation was not necessary. The cells were washed 
twice by repeating centrifugation and resuspension. This washing procedure did not 
affect cell viability and was enough to remove unloaded Fura-2-AM. 
d) Measurement of Intracellular Calcium Concentration, [Cti+ ]; 
Resuspended cells were transferred to a quartz cuvette at a volume of 500 µl and 
stirred continuously. Fluorescence intensity was measured by HITACHI F-2000 
fluorescence spectrophotometer. Fluorescence scanning time was usually 350 seconds 
which were enough to see the effects of ion channel modulators on basal levels and 
serum or carabchol-induced changes of intracellular Ca2+ concentrations. In order to see 
the effects of various drugs on basal, free intracellular Ca2+ concentrations, these drugs 
were added between 50 and 100 seconds after running experiments. In order to see the 
effects of ion channel modulators on agonist-induced increased intracellular Ca2+ 
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concentrations, these drugs were injected 3 minutes prior to initiating experiments, and 
serum or carbachol was added between 50 and 100 seconds after running experiments. 
All the drugs were injected using a Hamilton syringe (Hamilton Company, Reno, NE). 
Volume of the drugs did not exceed 10 µI. All experiments were done at 37'C. 
Autofluorescence of the cells was almost negligable and corrected when needed. 
Fluorescence emission (510 nm) was monitored with excitation wavelenghs cycling 
between 340 and 380 nm. At the end of an experiment, fluorescence maximum and 
minimum values at each excitation wavelengh were obtained by first lysing the cells with 
0.1 % Triton X-100 (maximum) and then adding 10 mM EGTA (minimum). With the 
maximum and minimum values, the 340:380 nm fluorescence ratios were converted into 
free Ca2+ concentrations using the formula and Fura-2 Ca2 + binding constant (224 nM) 
descibed by Grynkiewicz et al. (Grynkiewicz et al., 1985). The use of the 340/380 
excitation ratio for Fura-2 results in measurements of the intracellular Ca2 + concentration 
that are essentially independent of the actual amount of dye in the cell. Ratioing 
considerably reduces problems associated with measuring Ca2+ in cells of unequal 
thickness and offsets the effects of uneven dye loading, leakage and photobleaching. 
DaJa Analysis 
The qualitative data were shown as the relative changes of the free intracellular Ca2 + 
concentrations compared to those of basal levels. The quantatative data of the drug 
effects on the basal, free cytosolic Ca2+ concentrations were shown by % changes 
compared to control condition and determined using the following calculations: 
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% Change = ([Ca2+k i[Ca2+k h) x 100 
where [Ca2+lh and [Ca2+t,d represent the intracellular Ca2+ concentrations which were 
measured in the absence and in the presence of drugs, respectively. The quantatative 
data of the drug effects on agonist-induced increased intracellular Ca2+ concentrations 
were shown by % differences between agonists (serum or carbachol) alone and drug 
pretreatment groups, which calculated using the following equation: 
% Change = (A[Ca2+]i,d+/ A[Ca2+la ) x 100 
where A[Ca2+]i,d+a and A[Ca2+]i,a represent agonist-induced increased intracellular Ca2+ 
concentrations in the presence and in the absence of drugs, respectively. The data were 
expressed as mean + standard error of the mean (SEM) and were compared using one 
way analysis of variance (ANOVA) and Student-Newman-Keul's test for individual 
comparison. The data which have p value less than 0.05, were considered to be 
statistically significant. 
CHAPTER IV 
MECHANISM OF CALCIUM CHANNEL ANTAGONIST-INDUCED 
INHIBITION OF TUMOR CELL GROWTH 
A. Introduction 
Intracellular Ca2+ ions appear to play an important role in the regulation of a number 
of cellular processes including DNA synthesis and cell proliferation (Geck and Bereiter-
Hahn, 1991; Mendoza, 1988; Metcalfe et al., 1986; Whitfield, 1990; Whitfield et al., 
1987). Calmodulin (CaM) which may be activated by increased intracellular Ca2+ ions 
seems also to be involved in these processes (Rasmussen and Means, 1988). The 
intracellular Ca2+ ion is increased at anaphase initiation of the cell cycle (Boynton, 1988), 
and the level of CaM is also increased at the Gl/S border (Rasmussen and Means, 1988). 
These Ca2+ or CaM increases have shown to be inhibited by their antagonists, causing 
a block in DNA synthesis (Katayama et al., 1990; Ogata et al., 1991). In addition, CaM 
levels are significantly elevated in exponentially growing transformed cells, as well as 
are total cellular Ca2+ levels in many tumor cells (Veigl et al., 1982). The high Ca2+ 
level seems to be due to either the excessive influx of extracellular Ca2+ or the ability 
of neoplastic mitochondria to retain high concentrations of Ca2+ (Metcalfe et al., 1980). 
Thus, prolonged, abnormally high levels of intracellular Ca2+ may lead to increased 
activation of the Ca2+ second messenger system resulting in the exaggerated growth rate 
of certain malignant cells. 
The cell replication rate in vitro has been found to be positively correlated with Ca2+ 
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concentration in medium (Swierenga et al., 1978). The presence of Ca2+ in the culture 
medium is absolutely necessary for the stimulation of lymphocytes by lectin mitogens 
(Whitney and Sutherland, 1972), and calcium chloride stimulates in vitro cellular DNA 
synthesis (Maino et al., 1974). The Ca2+ ionophore A23187 can mimic the action of 
mitogens on the lymphocyte DNA synthesis (Lichtman et al., 1983). However, in cancer 
cells the dependence of cell proliferation upon extracellular Ca2+ concentration is 
controversial and appears to be cell type specific (Parsons et al., 1983; Shirakawa et al., 
1986; Simpson and Arnold, 1986; Simpson and Taylor, 1988). Simpson and coworkers 
have shown that HT-39 and MCF-7 human breast cancer cell lines and the HL-60 human 
promyelocytic leukemia cell line exhibit Ca2+ -dependent proliferation, while the growth 
of the L1210 leukemia cell line is inhibited by an increased extracellular Ca2+ 
concentration (Simpson and Arnold, 1986; Simpson and Taylor, 1988). Others have 
shown that removal of Ca2+ from the culture medium did not inhibit cell growth in 
transformed fibroblasts (Balk et al., 1979), liver hepatomas (Swierenga et al., 1978), 
mouse embryo 3T3 cells (Paul and Ristow, 1979) and human ovarian cells (Chan, 1989), 
whereas, with their untransformed ancestors, removal of Ca2+ from the medium altered 
cell growth. The weight of the evidence favors the argument that the dependence of 
cancer cell growth on extracellular Ca2+ is not as great that of normal cells (Chan and 
Howell, 1986; Swierenga et al., 1983). 
The recognition of the importance of intracellular Ca2+ in cellular proliferation 
stimulated many researchers to test the effect of drugs which reduce the transmembrane 
Ca2+ influx on cell growth. Using typical Ca2+ channel antagonists, e.g. verapamil or 
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nifedipine, the investigators have shown that cellular proliferation was inhibited by those 
drugs in mouse spleen lymphocytes (Kunert-Radek et al., 1990), human messangeal cells 
(Shultz and Raij, 1990), rat thyroid cells (Takada et al., 1990), human retinal glial cells 
(Puro and Mano, 1991) and rat neuroblasts (Pincus et al., 1991). Ca2+ channel 
antagonists also inhibit tumor cell growth as shown in HT-39 human breast cancer cell 
line (Taylor and Simpson, 1992), human glioma cells (Kunert-Radek et al., 1989), 
human prostatic tumor cells (Batra et al., 1991), human brain tumor cells (Schmidt et 
al., 1988), human lung cancer cells (Schuller et al., 1991) and human leukaemia cells 
(Brusterud, 1992). However, in these studies the cause-and-effect relationship has not 
been explored. Moreover, Ca2+ channel blockers have shown to bind to other sites other 
than Ca2+ channels and produce non-Ca2+ channel actions (Zemig, 1990; Nandi et al., 
1990; Pancrazio et al., 1991). Thus, the mechanisms of action of these drugs in tumor 
cell growth may involve Ca2+ channels as well as other effectors and are basically 
unknown. 
In addition to the effect on tumor cell growth, Ca2+ channel blockers have also been 
known to reverse multidrug resistance (MDR) to chemotherapeutic agents (Helson, 
1984). One basis for MDR within a given tumor cells resides with the ability of that cell 
to extrude cytotoxic compounds via active transport mechanism, thereby effectively 
reducing the available intracellular drug concentration (Helson, 1984). The P-
glycoprotein, the product of MDR gene is responsible for this extrusion action. Acquired 
resistance to anticancer drugs is associated with increased expression of the MDR gene. 
Interestingly, adenylyl cyclase and various plasma membrane channels, including the a 1 
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subunit of the L-type Ca2+ channel, possess a similar repeated transmembrane motif 
(Gottesman and Pastan, 1989). Although the Caz+ regulatory effects of the Ca2+ channel 
antagonists may likely be a candidate, the mechanisms of action of these drugs in the 
reversal of MDR is unknown. 
The data presented in this chapter describe the effects of some Ca2+ channel 
antagonists on both tumor cell growth and growth factor-induced increased intracellular 
Ca2+ using two nervous system tumor cell lines (astrocytoma, U-373 MG and 
neuroblastoma, SK-N-MC cell lines) as a model cellular system. Experiments were 
designed to elucidate the Ca2+-related mechanisms responsible for the regulation of the 
tumor cell growth by these drugs. The data demonstrate that the increased intracellular 
Ca2+ concentration is an important signalling mechanism for growth factor-induced cell 
proliferation and that the most of the increased Ca2+ is from intracellular Ca2+ store 
release. Furthermore, Ca2+ channel blockers can effectively inhibit tumor cell growth 
and their mechanisms of action appear to be closely related to the inhibition of growth 
factor-induced increased intracellular Caz+ concentration. Possible regulatory pathways 
regarding to this inhibition are discussed. 
B. Results 
Extracelluklr Calcium Dependency of Tumor Cell Growth 
Fig. 4.1 shows the effect of EGTA on tumor cell growth. Chelation of extracellular 
Ca2+ with EGTA inhibited the tumor cell growth in both U-373 MG human astrocytoma 
and SK-N-MC human neuroblastoma cell lines. This inhibition was dose-dependent. 
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Fig. 4.1. Effect of EGTA on the growth of U-373 MG human astrocytoma (closed 
circle) and SK-N-MC human neuroblastoma (open inverted triangle) cell lines. The 
cells were grown in MEM supplemented with 10% FBS in the absence or in the presence 
of various concentrations of EGT A in the culture medium. The cell number was 
counted 2 days after drug treatment. The results were expressed as a percent change of 
the number of the cells obtained in the absence of the drug. The data points represent the 
mean value of at least four replicate dishes with bars indicating SEM. 
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The inhibition of tumor cell growth by EGT A appeared not to be due to its cytotoxicity 
as shown in Figs. 4.9 and 4.10. These results can be interpreted to mean that during 
tumor cell proliferation, the influx of extracellular Ca2+ may occur and that EGTA will 
reduce the transmembrane concentration gradient for Ca2+ ion by lowering available 
extracellular Ca2+. Thus, the inhibition of Ca2+ influx ultimately leads to growth 
inhibition. However, since Ca2+ mobilization from internal stores without ca2+ influx 
seems to be involved in the proliferative signalling mechanisms in these cells, which will 
be described later, EGTA may indirectly affect growth factor-induced Ca2+ response. 
If extracellular Ca2+ is lowered, then the cell will be gradually depleted of Ca2+, i.e. 
intracellular stores will be reduced (Jin et al., 1992; Murphy and Miller, 1988). Thus, 
transmembrane Ca2+ concentration gradient is important for maintaining Ca2+ stores 
involving Ca2+ mobilization in response to agonist stimulation. Therefore, the EGTA 
action on tumor cell growth may be due to the reduction of available Ca2+ of internal 
stores. Alternatively, long term exposure of EGTA may enter into the cells and thus, 
chelate intracellular Ca2+, resulting in blunting growth factor-induced Ca2 + signalling 
mechanisms. However, these possibilities are only speculative, and the actual mechanism 
of EGTA is unknown. 
The increased extracellular Ca2+ concentration also led to growth-inhibitory effects 
on both tumor cell lines as shown in Fig. 4.2. Recent work has shown that a sustained 
increased cytosolic Ca2+ concentration is often linked to the onset of drug-induced 
cytotoxicity (Reviewed in Nicotera et al., 1992; Orrenius et al., 1989). The proposed 
cytotoxic mechanisms include the disruption of the cytoskeletal network and an 
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Fig. 4.2. Effect of high extracellular Ca2+ on the growth of U-373 MG human 
astrocytoma (closed circle) and SK-N-MC human neuroblastoma (open inverted 
triangle) cell lines. The cells were grown in MEM supplemented with 10 % FBS in the 
absence or in the presence of various concentrations of Ca2+ in the culture medium. 
The cell number was counted 2 days after Ca2+ treatment. The results were expressed 
as a percent change of the number of the cells obtained in the culture medium containing 
normal Cai+ concentration (l.8mM). The data points represent the mean value of at least 
four replicate dishes with bars indicating SEM. 
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uncontrolled activation of Ca2+ -stimulated catabolic enzymes, such as phospholipases, 
proteases and endonucleases. However, the effects of high extracellular Ca2+ 
concentration on the level of cytosolic Ca2+ has not been well described. If during cell 
proliferation Ca2+ influx occurs, then high extracellular Ca2+ concentration will increase 
the transmembrane concentration gradient for Ca2+ ions and, thus, possibly lead to a 
sustained increased intracellular Ca2+ concentration. However, the actual Ca2+ entry 
pathways are undefined, and how the intracellular Ca2+ regulatory mechanisms are 
disturbed is unknown. 
Calcium Channel Antagonist-Induced Inhibition of Tumor Cell Growth 
Structurally different Ca2+ channel antagonists were used in order to see the possible 
involvement of Ca2+ channels in tumor cell growth. The culture medium and Ca2+ 
channel antagonists were replaced every day. The in vivo pharmacokinetic data show 
that the half-lives of these drugs in healthy volunteers is less than 10 hours, although the 
values are variable depending on the experimental conditions (Kates, 1987). However, 
no in vitro data on half-lives of these drugs are available but the half-lives would be 
expected to be much longer than the in vivo half-lives. Figs. 4.3 and 4.4 show the 
effects of Ca2+ channel antagonists on the growth of U-373 MG astrocytoma and SK-N-
MC neuroblastoma tumor cells, respectively. In both cell lines these typical Ca2+ 
channel antagonists inhibited cell growth in a dose-dependent manner. Verapamil was 
the most effective in both cell lines. The order of the potency is verapamil ) nifedipine 
) diltiazem in both cell lines. However, the concentrations of half-maximum effect 
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Fig. 4.3. Effect of Ca2+ channel antagonists on the growth of U-373 MG human 
astrocytoma cell lines. The cells were grown in MEM supplemented with 10% FBS in 
the absence or in the presence of various concentrations of verapamil (closed circle), 
nifedipine (open inverted triangle) or diltiazem (closed inverted triangle) in the culture 
medium. The cell number was counted 2 days after drug treatment. The results were 
expressed as a percent change of the number of the cells obtained in the absence of the 
drug. The data points represent the mean value of at least four replicate dishes with bars 
indicating SEM. 
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Fig. 4.4. Effect of Caz+ channel antagonists on the growth of SK-N-MC human 
neuroblastoma cell lines. The cells were grown in MEM supplemented with 10% FBS 
in the absence or in the presence of various concentrations of verapamil (closed circle), 
nifedipine (open inverted triangle) or diltiazem (closed inverted triangle) in the culture 
medium. The cell number was counted 2 days after drug treatment. The results were 
expressed as a percent change of the number of the cells obtained in the absence of the 
drug. The data points represent the mean value of at least four replicate dishes with bars 
indicating SEM. 
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(EC50) of these drugs are far greater than those in the inhibition of Ca2+ channels (far less 
than µM). Thus, this results suggest that the inhibition of the tumor cell growth induced 
by these drugs may be less likely due to the inhibition of voltage-gated ca2+ channels. 
Alternatively, in these tumor cells totally different type of Ca2+ channels may exist which 
require much higher concentrations of antagonists. Another possibility may exist that 
these Ca2+ channel antagonists may have other binding sites and produce effects other 
than the inhibition of Ca2+ channels (Zemig, 1990). For example, the functions of 
protein kinase C (PKC) and calmodulin (CaM) which are implicated in cell proliferation 
(Rasmussen and Rasmussen, 1986; Rozengurt, 1986), can be inhibited by these Ca2+ 
channel antagonists. Thus, the growth-inhibitory effects of these drugs may be due to 
their regulatory roles of PKC and/or CaM. 
In this study the cell growth was assessed by counting the number of cells. Thus, 
the results might include two different phenomena: cell proliferation and cell death. 
However, the cytotoxic mechanism can be excluded in their growth inhibition of the 
tumor cells, since the cytotoxicity assay using the trypan blue exclusion method (Bowles 
et al., 1990; Schanne et al., 1979; Schmidt et al., 1988) shown in Figs. 4.9 and 4.10 
demonstrated that with the exception of Ni2+ no significant differences existed between 
Ca2+ channel antagonists and control in both tumor cell lines. Thus, their growth-
inhibitory effects of tumor cells are most likely due to their effects on tumor cell 
proliferation. However, since this cytotoxicity assay using the trypan blue exclusion 
method may fail to detect disintegrated cells, this limitation of the method must be 
considered in the interpretation of the data. 
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Inorganic Ca2+ channel antagonists, e.g. Co2+ and Ni2+, also showed the inhibition 
of tumor cell growth in a dose-dependent manner illustrated in Figs. 4.5 and 4.6. Co2+ 
was more effective than Ni2+ in both cells. Since cytotoxicity assay (Figs. 4.9 and 4.10) 
showed that Ni2+ but not Co2+ was cytotoxic to both tumor cells, the growth-inhibitory 
action of Ni2+ may be due to also its cell-killing effect. In addition, Ni2+ has shown to 
be a potent carcinogen in experimental animals (fveito et al., 1989). This carcinogenic 
effect of Ni2+ may be related to its cytotoxicity since carcinogenecity induced by a 
certain chemical is often paradoxically caused by its cytotoxic effect (Ames and Gold, 
1990). However, the actual mechanism of Ni2+ in carcinogenecity is not known (fveito 
et al., 1989). Interestingly, Ni2+ binds to CaM allosterically with Ca2 + ions and, thus, 
disturbs physiological functions of CaM (Raos and Kasprzak, 1989). Since CaM has 
numerous essential roles in cellular physiology including cell proliferation, the inhibition 
of the functions of CaM may induce cell cytotoxicity and/or tumorigenecity. 
The inhibitory effects of various organic and inorganic Ca2+ channel antagonists on 
the tumor cell growth may be related to their interactions with Ca2+ channels. If Ca2+ 
influx is important in tumor cell growth, the blockade of the Ca2+ entry pathway could 
give rise to the inhibition of cell growth. However, since the role of Ca2+ influx in 
tumor cell growth is not known and these drugs have multiple actions, the experiments 
dealing with intracellular Ca2+ measurements were designed and pursued in order to 
elucidate the actual mechanism of action of these drugs in tumor cell growth. 
Moreover, as illustrated in Fig. 4.7, a Ca2+ channel agonist, Bay K-8644 did not 
induce a significant alteration of the growth of both tumor cells up to 4µM . . This result 
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Fig. 4.5. Effect of inorganic Ca2+ channel antagonists on the growth of U-373 MG 
human astrocytoma cell lines. The cells were grown in MEM supplemented with 10% 
FBS in the absence or in the presence of various concentrations of cobalt (closed circle) 
or nickel (open inverted triangle) in the culture medium. The cell number was counted 
2 days after drug treatment. The results were expressed as a percent change of the 
number of the cells obtained in the absence of the drug. The data points represent the 
mean value of at least four replicate dishes with bars indicating SEM. 
120 
100 
80 
60 
40 
20 
SK-N-MC human neuroblastoma 
• 
\J 
cobalt 
nickel 
.,,_ 
'l 
' 
' 
' 
' 
' 
' 
' 
' 
0 ~~~~~~~~~~~~---'-~'--'-'-'-'-'-----'9<..-'-'1'--'-'-'-LLJ 
10-7 
Drug Concentration (M) 
58 
Fig. 4.6. Effect of inorganic CaH channel antagonists on the growth of SK-N-MC 
human neuroblastoma cell lines. The cells were grown in MEM supplemented with 
10% FBS in the absence or in the presence of various concentrations of cobalt (closed 
circle) or nickel (open inverted triangle) in the culture medium. The cell number was 
counted 2 days after drug treatment. The results were expressed as a percent change of 
the number of the cells obtained in the absence of the drug. The data points represent the 
mean value of at least four replicate dishes with bars indicating SEM. 
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Fig. 4. 7. Effect of Bay K-8644 on the growth of U-373 MG human astrocytoma 
(closed circle) and SK-N-MC human neuroblastoma (open inverted triangle) cell 
lines. The cells were grown in MEM supplemented with 10 % PBS in the absence or in 
the presence of various concentrations of Bay K-8644 in the culture medium. The cell 
number was counted 2 days after drug treatment. The results were expressed as a 
percent change of the number of the cells obtained in the absence of the drug. The data 
points represent the mean value of at least four replicate dishes with bars indicating 
SEM. 
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further suggests that at least voltage-sensitive L-type Ca2+ channels are not involved in 
the tumor cell growth. However, this does not imply that Ca2+ signals are not important 
in the process of the cell proliferation. Internal Ca2+ release may be enough to trigger 
intracellular signalling mechanisms which ultimately lead to cell division. Thus, the 
intracellular Ca2+ measurements are required to determine the significance of Caz+ 
signals as well as elucidating the targets for Ca2+ channel antagonists in terms of the 
regulation of the cell proliferation. 
A Receptor-Operated ca2+ Channel Blocker, SK&F 96365 Is a Potent Inhibitor of 
Tumor Cell Growth 
Recently, the novel Caz+ entry mechanism into the cells, e.g. receptor-mediated Ca2+ 
entry (RMCE) by occupation of membrane receptors has been described in many cellular 
systems which are mainly non-excitable cells (Reviewed in Putney, Jr., 1990; Rink, 
1990; Taylor, 1990). An operational definition of RMCE is "an influx of Ca2+ 
consequent to receptor occupation and not dependent on depolarization that generates a 
biologically, significantly increased intracellular Ca2+ concentration" (Rink, 1990). The 
function and mechanism of RMCE are less well understood compared to those of voltage-
gated Ca2+ entry. However, possible important physiological functions of RMCE have 
been suggested: localized Ca2+ signalling, rapid signalling in non-excitable cells, 
maintenance of Ca2+ signals, refilling of discharged internal Ca2+ pools and control of 
the intracellular Ca2+ spiking (Rink, 1990). 
Merritt and associates developed a novel compound, SK&F 96365, which is 
structurally distinct from classic Ca2+ antagonists and which effectively blocks RMCE 
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(Merritt et al., 1990). This RMCE blocking action may result from either direct 
interaction with Ca2+ channels or indirect mechanisms including the inhibitory effect on 
cytochrome P-450 (Garcia-Sancho et al., 1992). Since SK&F 96365 has such a 
regulatory role in the Ca2+ signalling mechanism which is important in cell growth, the 
effect of this drug on tumor cell growth would be very interesting. 
The growth of the tumor cells was inhibited by SK&F 96365 in a dose-dependent 
fashion shown in Fig. 4.8. The EC50 of this inhibition by the drug is very comparable 
to that of RMCE in human platelets, human neutrophils and human umbilical vein 
endothelial cells (Rink, 1990). Although this RMCE inhibition may be suspected as a 
mechanism of inhibition of the tumor cell growth, the exact mechanism of this drug is 
not known. Thus, further investigations require observing its effect on the intracellular 
Ca2+ signals. 
The Re'lationship between Carbachol-Induced Increased Intracellular Calcium and 
Tumor Cell Growth in U-373 MG Human Astrocytoma Cell Une 
Carbachol (Carb), a cholinergic agonist, was chosen as an agonist to induce alteration 
of intracellular Ca2+ concentration in U-373 MG human astrocytoma cell line since many 
nonexcitable cells as well as neuronal cells respond to stimulation by this drug with a 
biphasic elevation of intracellular Ca2+ concentration (Felder et al., 1992; Fischer et al., 
1992; Hiramatsu et al., 1992; Lambert et al., 1990; Shuttleworth and Thompson, 1992). 
The initial transient phase (peak) is due to the release of intracellular Ca2+ stores, 
whereas a secondary, sustained elevation of intracellular Ca2+ (plateau) is maintained by 
Ca2+ entry from the extracellular space into the cytosol (Felder et al., 1992; Lambert et 
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Fig. 4.8. Effect of SK&F 96365 on the growth of U-373 MG human astrocytoma 
(closed circle) and SK-N-MC human neuroblastoma (open inverted triangle) cell 
lines. The cells were grown in MEM supplemented with 10% FBS in the absence or in 
the presence of various concentrations of SK&F 96365, a receptor-operated Ca2+ 
channel blocker, in the culture medium. The cell number was counted 2 days after drug 
treatment. The results were expressed as a percent change of the number of the cells 
obtained in the absence of the drug. The data points represent the mean value of at least 
four replicate dishes with bars indicating SEM. 
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Fig. 4.9. Cytotoxic effect of EGTA or Ca2+ channel antagonists on U-373 MG 
human astrocytoma cell line. The cells were grown in MEM supplemented with 10% 
FBS in the absence or in the presence of the drugs in the culture medium. Cell 
cytotoxicity was assayed by trypan blue extrusion method 2 days after drug treatment. 
The results were expressed as a percent change of the number of dead cells obtained in 
the absence of the drug. Each column represents the mean value of four replicates with 
bars indicating SEM. The data were compared using one way ANOVA and Student-
Newman-Keul's test for individual comparison. (*p<0.05 compared to control 
condition). 
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Fig. 4.10. Cytotoxic effect of EGTA or Caz+ channel antagonists on SK-N-MC 
human neuroblastoma cell line. The cells were grown in MEM supplemented with 
10% FBS in the absence or in the presence of the drugs in the culture medium. Cell 
cytotoxicity was assayed by trypan blue extrusion method 2 days after drug treatment. 
The results were expressed as a percent change of the number of dead cells obtained in 
the absence of the drug. Each column represents the mean value of four replicates with 
bars indicating SEM. The data were compared using one way ANOV A and Student-
Newman-Keul's test for individual comparison. (*p<0.05 compared to control 
condition).:. 
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al., 1992). This is referred to as a receptor-mediated Ca2+ entry (RMCE) (Putney, 1990; 
Sage et al., 1992). 
a) Carbachol-lnduced Intracellular Calcium Increase Is not Dependent upon 
Extracellular Calcium Concentration 
As shown in Fig. 4.11., carbachol rapidly increased intracellular Ca2+ concentration 
which was measured in Fura-2 loaded U-373 MG human astrocytoma cell line. In 
normal extracellular Ca2+ concentration (l.3mM), the response of these cells to Carb was 
transient without any significant, sustained increased intracellular Ca2+ concentration 
which was observed in many other cells (Felder et al., 1992; Fischer et al., 1992; 
Hiramatsu et al., 1992; Lambert et al., 1990; Shuttleworth and Thompson, 1992). This 
contradictory findings in our model cellular system suggest that this tumor cell may have 
a different response to carbachol stimulation resulting in no receptor-mediated Ca2+ 
influx. Since this Ca2+ entry has been suggested to contribute to the refilling of empty 
IP3-sensitive stores, the absence of this pathway in this tumor cell further suggests that 
other mechanisms may exist for refilling the empty stores, for example, through "secret 
pathway" which allows Ca2+ to pass from the extracellular space to the stores without 
entering the cytoplasm (Taylor, 1990). In order to ascertain no contribution of Ca2+ 
influx from the extracellular space to Carb-induced increased intracellular Ca2+ 
concentration, the experiment was done with the resuspending medium containing 0 
Ca2+. The results showed no differences of Carb-induced increased intracellular Caz+ 
concentration between normal Ca2+ -containing and Ca2+ -free media (Fig. 4.11). Thus, 
the Carb-induced increased intracellular Ca2+ concentration is mainly due to internal store 
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Fig. 4.11. Extracellular Cai+ concentration independency of carbachol (0.8mM)-
induced increased intracellular Cai+ concentration in U-373 MG human astrocytoma 
cell line. Aliquots of 5xl06 cells/ml were incubated with 2µM of Fura-2-AME for 60 
minutes at room temperature. The cells were washed, resuspended in the buffer solution 
containing 0 Ca2+ or l.3mM Cai+ and transferred to a quartz cuvette for fluorescence 
measurements. The data represent net increases of intracellular Ca2+ concentration with 
time. The arrow shows the time point for the addition of carbachol. 
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release. 
b) Carbachol-lnduced Increased Intracellular Calcium Concentration ls Dose-
Dependent and Muscarinic Receptor-Mediated 
Figs. 4.12 and 4.13 show the dose-response relationships in Carb-induced increased 
intracellular Ca2+ concentration. The results clearly illustrate a dose-dependent increase 
of intracellular Ca2+ by Carb and suggest that this effect of Carb may be evoked by a 
receptor-mediated mechanism. Thus, a muscarinic receptor antagonist, atropine was 
applied prior to the addition of Carb. As shown in Fig. 4.14, the pretreatment of 
atropine completely abolished the effect of Carb, which demonstrates that the Carb-
induced response results from the activation of muscarinic receptors. The stimulation of 
the muscarinic receptors probably generates IP3 which can open Ca2+ channels of the 
endoplasmic reticulum and release Ca2+ from that store (Lambert and Nahorski, 1990). 
The concentrations of Carb up to a few mM range did not saturate the Carb-induced 
response. 
c) Carbachol-lnduced Increased Tumor Cell Growth ls Dose-Dependent 
If the increased intracellular Ca2+ concentration is an important signalling mechanism 
in the tumor cell proliferation, Carb is expected to increase tumor cell growth, since 
Carb actually increased the intracellular Ca2+ concentration (Figs. 4.12 and 4.13). Thus, 
the growth response of the tumor cells to Carb was examined in order to see whether 
Carb has an effect on tumor cell growth. As illustrated in Fig. 4.15, Carb increased the 
tumor cell growth in a dose-dependent manner. Carb induced both the enhancement of 
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Fig. 4.12. Dose-dependent increase of intracellular Cal+ concentration by carbachol 
in U-373 MG human astrocytoma cell line. Aliquots of 5xla6 cells/ml were incubated 
with 2µM of Fura-2-AME for 60 minutes at room temperature. The cells were washed, 
resuspended in the buffer solution containing 0 Ca2+ and transferred to a quartz cuvette 
for fluorescence measurements. The data represent net increases of intracellular Ca2+ 
concentration with time. The arrow shows the time point for the addition of various 
concentrations of carbachol. 
69 
500 
U-373 MG hu1nan astrocytoma cells 
450 
* 
400 
* 350 
-0 
~ 300 
* 
-f-) 
~ 
0 250 u 
~ 
0 200 
~ 
150 
100 
50 
0 
Cont O.lmM 0.4mM 0.81nM 
Carb Carb Carb 
Fig. 4.13. Effect of carbachol on intracellular Ca2+ concentration in U-373 MG 
human astrocytoma cell line. Aliquots of 5xle>6 cells/ml were incubated with 2µM of 
Fura-2-AME for 60 minutes at room temperature. The cells were washed, resuspended 
in the buffer solution containing 0 Ca2+ and transferred to a quartz cuvette for 
fluorescence measurements. The results were expressed as a percent change of the 
intracellular Cai+ concentration induced by various concentrations of carbachol 
compared to basal level. Each column represents the mean value of four replicates with 
bars indicating SEM. The data were compared using one way ANOVA and Student-
Newman-Keul's test for individual comparison. (*p<0.05 compared to control). 
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Fig. 4.14. Abolishment of carbachol (0.8mM)-induced increased intracellular Cai+ 
concentration by the pretreatment of atropine (lOOµM) in U-373 MG human 
astrocytoma cell line. Aliquots of 5x106 cells/ml were incubated with 2µM of Fura-2-
AME for 60 minutes at room temperature. The cells were washed, resuspended in the 
buffer solution containing 0 Ca2+ and transferred to a quartz cuvette for fluorescence 
measurements. The data represent net increases of intracellular Ca2+ concentration with 
time. The arrow shows the time point for the addition of carbachol. Atropine was 
treated for 3 minutes before starting the experiment. 
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Fig. 4.15. Effect of carbachol on the growth of U-373 MG human astrocytoma cell 
lines. The cells were grown in MEM supplemented with 0.1 % PBS in the absence or 
in the presence of various concentrations of carbachol in the culture medium. The cell 
number was counted 2 days after drug treatment. The results were expressed as a 
percent change of the number of the cells obtained in the absence of the drug. Each 
column represents the mean value of at least four replicates with bars indicating SEM. 
The data were compared using one way ANOVA and Student-Newman-Keul's test for 
individual comparison. (*p<0.05 compared to control). 
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the tumor cell growth and the increase of the intracellular ca2+ concentration at a same 
concentration (Figs. 4.13 and 4.15). These results suggest that the increased intracellular 
Ca2+ concentration induced by growth factors (e.g. Carb) may be an important signalling 
mechanism in the proliferation of U-373 MG human astrocytoma cell line and that Carb 
is a very useful drug for investigating the role of Ca2+ signals in the cell proliferation. 
Therefore, Carb was used as an agonist for the elevation of intracellular Ca2+ 
concentration in further experiments where the effects of Ca2+ channel antagonists on the 
Carb-induced response were examined. 
Serum-Induced lntracellula.r Calcium Increase Is Dose-Dependent and not Dependent 
upon Extracellula.r Calcium Levels in SK-N-MC Human Neurobla.stoma Cell Line 
Fetal bovine serum (FBS) increased intracellular Ca2+ concentration in a dose-
dependent manner in SK-N-MC human neuroblastoma cell line as shown in Fig. 4.16. 
This increase appeared to be independent of the level of extracellular Ca2+ as illustrated 
in Fig. 4.17. These results suggest that serum component(s) can evoke intracellular Ca2+ 
increase through a receptor-mediated mechanism and that this increased intracellular Ca2+ 
is mainly due to internal Ca2+ release. These results further suggest that the increased 
intracellular Ca2+ concentration may be linked to the mechanism of the serum-induced 
proliferation of this cell line. 
Since serum is composed of multiple components and heterogeneous from batch to 
batch, the identification of actual agonist(s) for elevating intracellular Ca2+ is very 
difficult. Thus, the usefulness of serum as an agonist may be criticized. Therefore, in 
order to find an agonist which increases both tumor cell growth and intracellular Ca2+ 
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Fig. 4.16. Dose-dependent increase of intracellular Ca2+ concentration by serum in 
SK-N-MC human neuroblastoma cell line. Aliquots of 5xl<J6 cells/ml were incubated 
with 2µM of Fura-2-AME for 60 minutes at room temperature. The cells were washed, 
resuspended in the buffer solution containing 0 Ca2+ and transferred to a quartz cuvette 
for fluorescence measurements. The data represent net increases of intracellular Ca2+ 
concentration with time. The arrow shows the time point for the addition of various 
concentrations of serum. 
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Fig. 4.17. Effect of EGTA (lmM) on serum (2%)-induced increased intracellular 
Cai+ concentration in SK-N-MC human neuroblastoma cell line. Aliquots of 5xl06 
cells/ml were incubated with 2µM of Fura-2-AME for 60 minutes at room temperature. 
The cells were washed, resuspended in the buffer solution containing 1.3mM Ca2+ and 
transferred to a quartz cuvette for fluorescence measurement. The data represent net 
increases of intracellular Ca2+ concentration with time. The arrow shows the time point 
for the addition of serum. Cells were treated with EGTA for 3 minutes before starting 
the experiment. 
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concentration, the experiments were done using compounds which have shown such 
characteristics in other cellular systems, such as carbachol, serotonin, phenylephrine, 
bradykinin, angiotensin-II and Met-enkephalin. However, these compounds did not 
induce a significant alteration of intracellular Ca2+ concentration in SK-N-MC human 
neuroblastoma cell line (data not shown). Therefore, serum was continued to be used 
to stimulate proliferation of these cells. Thus, the homogeneous composition of the 
serum was required. To this end, the serum used in these experiments was prepared 
from a single batch, divided into small vials after well mixing and stored in a 
refrigerator. In addition, since the experiments using this serum actually showed a dose-
related response (Fig. 4.16), the serum was used as an agonist for elevating intracellular 
Ca2+ for further experiments where the effect of various Ca2+ channel antagonists on an 
agonist-induced increased intracellular Ca2+ concentration was investigated. 
Inhibition of an Agonist-Induced Increased Intracellular Calcium Concentration by 
Calcium Channel Antagonists 
As previously shown in Figs. 4.11 and 4.17, a growth factor-induced release of Ca2+ 
from the internal stores seems to be an important signal transduction mechanism in the 
proliferation of tumor cells. Since the Ca2+ channel antagonists inhibited the growth of 
both tumor cell lines in a dose-dependent fashion (Figs. 4.3 - 4.6 and 4.8), their growth-
inhibitory effects may be related to this signalling mechanism. Thus, the effects of these 
drugs on an agonist-induced release of Ca2+ from the internal stores were investigated 
in order to elucidate the mechanism of their actions. In these experiments carbachol and 
serum were used as agonists in U-373 MG human astrocytoma and SK-N-MC human 
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neuroblastoma cell line, respectively. 
Fig. 4.18 shows the effects of the Ca2+ channel antagonists on Carb-induced release 
of Ca2+ from the internal stores in Fura-2 loaded U-373 MG human astrocytoma cell 
line. Since the resuspending buffer solution containing 0 ca2+ was used in these 
experiments, the Carb-induced increased intracellular Ca2+ concentration would result 
from the internal store release. The concentration of Ca2+ channel antagonists was chosen 
on the basis of their effects on the tumor cell growth. Fig. 4.19 shows the effects of 
Ca2+ channel antagonists on Carb-induced response, in which the data were expressed 
by % changes compared to the effect of Carb alone. These results (Figs. 4.18 and 4.19) 
clearly demonstrate that pretreatment with these drugs significantly reduced the Carb-
induced release of Ca2+ from the internal stores. Verapamil was shown to be the most 
effective, which is well correlated with the results of the studies on the tumor cell 
growth. SK&F 96365 showed significant inhibition at a relatively high concentration 
compared to the growth study. These results suggest that SK&F 96365 may have other 
mechanisms in addition to the impairment of the intracellular Ca2+ signals in its 
inhibitory effect on tumor cell growth. 
The effects of Ca2+ channel antagonists on a serum-induced release of Ca2+ from the 
internal stores in Fura-2 loaded SK-N-MC human neuroblastoma cell line were also 
investigated, and the results were shown in Figs. 4.20 and 4.21. These results show that 
these drugs also significantly inhibited the serum-induced response. In the growth studies 
of the tumor cells, all the Ca2+ channel antagonists were more effective in SK-N-MC 
human neuroblastoma than U-373 MG human astrocytoma cell line. In contrast to this 
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Fig. 4.18. Effect of Ca2+ channel antagonists on carbachol (0.SmM)-induced 
intracellular Ca2+ mobilization in U-373 MG human astrocytoma cell line. Aliquots 
of 5xl06 cells/ml were incubated with 2µM of Fura-2-AME for 60 minutes at room 
temperature. The cells were washed, resuspended in the buffer solution containing 0 
Ca2+ and transferred to a quartz cuvette for fluorescence measurements. The data 
represent net increases of intracellular Ca2+ concentration with time. The arrow shows 
the time point for the addition of carbachol. Ca2+ channel antagonists were treated for 
3 minutes before starting the experiment. 
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Fig. 4.19. Quantitative changes of carbachol (0.8mM)-induced intracellular CaH 
mobilization by CaH channel antagonists in U-373 MG human astrocytoma cell line. 
Aliquots of 5x106 cells/ml were incubated with 2µM of Fura-2-AME for 60 minutes at 
room temperature. The cells were washed, resuspended in the buffer solution containing 
0 Ca2+ and transferred to a quartz cuvette for fluorescence measurements. The results 
were expressed as a percent change of the increased intracellular Cai+ concentration 
induced by the drugs compared to carbachol alone. Each column represents the mean 
value of at least five replicates with bars indicating SEM. The data were compared using 
one way ANO VA and Student-Newman-Keul's test for individual comparison. (*p < 0.05 
compared to carbachol alone). 
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Fig. 4.20. Effect of Cai+ channel antagonists on serum (2%)-induced intracellular 
Cai+ mobilization in SK-N-MC human neuroblastoma cell line. Aliquots of 5xl06 
cells/ml were incubated with 2µM of Fura-2-AME for 60 minutes at room temperature. 
The cells were washed, resuspended in the buffer solution containing 0 Caz+ and 
transferred to a quartz cuvette for fluorescence measurements. The data represent net 
increases of intracellular Ca2+ concentration with time. The arrow shows the time point 
for the addition of serum. Ca2+ channel antagonists were treated for 3 minutes before 
starting the experiment. 
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Fig. 4.21. Quantitative changes of serum (2%)-induced intracellular Ca2+ 
mobilization by Ca2+ channel antagonists in SK-N-MC human neuroblastoma cell 
line. Aliquots of 5xl06 cells/ml were incubated with 2µM of Fura-2-AME for 60 
minutes at room temperature. The cells were washed, resuspended in the buffer solution 
containing 0 Ca2+ and transferred to a quartz cuvette for fluorescence measurements. 
The results were expressed as a percent change of the increased intracellular Ca2+ 
concentration induced by the drugs compared to serum alone. Each column represents 
the mean value of at least five replicates with bars indicating SEM. The data were 
compared using one way ANOVA and Student-Newman-Keul's test for individual 
comparison. (*p < 0.05 compared to serum alone). 
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result, the inhibitory effects of Caz+ channel antagonists on the serum-induced 
intracellular Ca2+ responses were much less prominent in SK-N-MC human 
neuroblastoma than U-373 MG human astrocytoma cell line. Thus, these results suggest 
that the mechanism of action of Ca2+ channel antagonists in tumor cell growth may differ 
in these tumor cell lines and that the signalling mechanism of increased intracellular Ca2+ 
concentration may have a greater contribution to the growth of the U-373 MG human 
astrocytoma than to that of the SK-N-MC human neuroblastoma cell line. 
The Inhibinon of Agonist-Induced Intracellular Calcium Responses by Calcium 
Channel Antagonists is not Related to Their lfffects on Basal Levels of Free 
Intracellular Calcium 
The intracellular free Ca2+ concentration appears to be tightly regulated via several 
different mechanisms (Carafoli, 1987; Rasmussen and Rasmussen, 1990). Thus, after 
the elevation of the cytosolic free Caz+ concentration by a stimulus, the level is expected 
to be returned to a normal value. However, if these homeostatic regulatory mechanisms 
are impaired by a drug, the intracellular Ca2+ level will be remained elevated after an 
agonist stimulation. Interestingly, high micromolar concentrations of verapamil have 
been shown to lead to a rapid, sustained elevation of the intracellular Ca2+ concentration 
in the isolated rat osteoblast (Zaidi et al., 1990). In addition, Taylor and Simpson found 
that the treatment of amlodipine, a Ca2+ channel antagonist, caused a rapid concentration-
dependent decrease of the intracellular Ca2+ concentration in the HT-39 human breast 
cancer cell line (Taylor and Simpson, 1992). Thus, these alterations of the basal, 
cytosolic Ca2+ concentration may result in an altered response to an agonist stimulation. 
Therefore, the inhibitory effects of Ca2+ channel antagonists on agoriist-induced 
82 
elevations of the intracellular Ca2+ concentration, shown in this study, may be due to 
their effects on the basal levels of cytosolic free Ca2+. 
In order to test this possibility, the effects of Ca2+ channel antagonists alone on the 
basal levels of free cytosolic Ca2+ in both Fura-2 loaded tumor cells were investigated. 
As depicted in Figs. 4.22 and 4.23, these drugs alone did not induce a significant 
alteration of the basal, intracellular Ca2+ concentration in either cell lines. Therefore, 
these results further suggest that the inhibition of agonist-induced intracellular Ca2+ 
responses evoked by Ca2+ channel antagonists may be not due to their effects on the 
basal levels of free cytosolic Ca2+. 
Throughout these experiments involving intracellular Ca2+ measurements, the basal, 
free intracellular Ca2+ concentrations of the cells were carefully monitored in the 
beginning in order to prevent possible contamination of these measurements by dead 
cells. Dead cells are likely to have increased intracellular Ca2+ levels. Thus, by 
monitoring basal intracellular Ca2+ levels, the existence of dead cells in the monitoring 
cell suspension can be indirectly checked. Variations of basal levels of intracellular Ca2+ 
concentration occured in both types of cells as shown in Table 4 .1, ranging between 100 
and 150 nM and between 150 and 200 nM in SK-N-MC human neuroblastoma and U-373 
MG human astrocytoma cell lines, respectively. These levels indicated relatively stable 
basal level of intracellular Ca2+ and minimal contamination by possible dead cells. 
C. Discussion 
The major findings of this study are: 1) In tumor cell proliferation the increased 
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Fig. 4.22. No effect of Caz+ channel antagonists on basal, free cytosolic Caz+ 
concentration in U-373 MG human astrocytoma cell line. Aliquots of 5xl<J6 cells/ml 
were incubated with 2µM of Fura-2-AME for 60 minutes at room temperature. The cells 
were washed, resuspended in the buffer solution containing 0 Ca2+ and transferred to a 
quartz cuvette for fluorescence measurements. The results were expressed as a percent 
change of intracellular Ca2+ concentration induced by the drugs compared to control. 
Each column represents the mean value of at least five replicates with bars indicating 
SEM. The data were compared using one way ANOVA and Student-Newman-Keul's test 
for individual comparison. 
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Fig. 4.23. No effect of CaH channel antagonists on basal, free cytosolic CaH 
concentration in SK-N-MC human neuroblastoma cell line. Aliquots of 5xl<J6 cells/ml 
were incubated with 2µM of Fura-2-AME for 60 minutes at room temperature. The cells 
were washed, resuspended in the buffer solution containing 0 Ca2+ and transferred to a 
quartz cuvette for fluorescence measurements. The results were expressed as a percent 
change of intracellular Ca2+ concentration induced by the drugs compared to control. 
Each column represents the mean value of at least five replicates with bars indicating 
SEM. The data were compared using one way ANOVA and Student-Newman-Keul's test 
for individual comparison. 
Table 4.1. Basal, free intracellular Ca2+ concentrations of tumor cells 
Cell Line 
Mean 
SEM 
Minimum 
Maximum 
Range 
n 
Intracellular Ca2+ concentration [nM] 
U-373 MG 
173.1 
3.0 
151.0 
198.0 
47.0 
20 
SK-N-MC 
131.8 
3.1 
105.0 
156.0 
51.0 
20 
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intracellular Ca2+ concentration which results from the release of Ca2+ from the internal 
stores, is an essential signal transduction mechanism; 2) the blockade of this signalling 
mechanism by Ca2+ channel antagonists results in the inhibition of the tumor cell growth. 
Signal Transductional Role of Increased Intracellular Calcium Concentration from 
Internal Store Release in Tumor Cell Proliferation 
The importance of increased intracellular Ca2+ concentration in cell proliferation has 
been suggested from many studies which have used pharamacological agents including 
Ca2+ channel blockers to inhibit growth factor-induced increased cytosolic Ca2+ 
concentration or used low amount of Ca2+ in the culture medium (Batra et al., 1991; 
Block et al., 1989; Ogata et al., 1991; Olsen et al., 1991; Shultz and Raij, 1990). Thus, 
these results suggest that during cell proliferation, the increased intracellular Ca2+ 
concentration occurs and that this Ca2+ increase is achieved through the influx of Ca2+ 
from the extracellular space. On the contrary the results of the present study, using brain 
tumor cells, showed that carbachol or serum which acted as growth factors, induced the 
release of Ca2+ from the internal stores without a significant Ca2+ influx from the 
extracellular space (Figs. 4.11 and 4.17). Thus, the results in these tumor cell systems 
suggest that the increased intracellular Ca2+ concentration due to the internal store release 
rather than Ca2+ influx from the extracellular space is involved in cell proliferation. 
The establishment of a direct cause-and-effect relationship between growth factor-
induced transiently increased intracellular Ca2+ concentrations and DNA synthesis is 
difficult since these two events occur separately over a lengthy period of time (24-36 
hours). However, the recent observations of Diliberto et al. demonstrate that early 
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alterations in cytosolic free Ca2+ concentration (occuring within seconds to minutes) 
following platelet-derived growth factor (PDGF) stimulation are required for subsequent 
DNA synthesis in both BALB/c3T3 fibroblasts and vascular smooth muscle cells 
(Diliberto et al., 1991). Thus, in the tumor cell lines, used in the present study, only 
a transiently increased intracellular Ca2+ concentration due to internal store release may 
be enough to evoke ultimate cell proliferation. 
Proposed Mechanism of Inhibitory Actions of Calcium Channel Antagonists in Tumor 
Cell Growth 
Although the mechanism of action of Ca2+ channel antagonists in the inhibition of 
tumor cell proliferation has been suggested to be due to their inhibitory effects on Caz+ 
influx, the intracellular Ca2+ concentration has not been directly measured in these 
studies (Brusterud, 1992; Kunert-Radek et al., 1989). Moreover, this notion about the 
mechanism of action of Ca2+ channel antagonists in the regulation of cell proliferation 
has been challenged. For example, in the 45Ca uptake studies, Schmidt and his associates 
suggested that the growth-inhibitory effects of verapamil appeared to be not due to Ca2+ 
influx or efflux in human medulloblastoma cells (Schmidt et al., 1988). Thus, in order 
to elucidate the mechanism of action of Ca2+ channel antagonists in the present study, 
the effects of these drugs on both tumor cell growth and an agonist-induced increased 
intracellular Ca2+ concentration were investigated using human brain tumor cell lines. 
The results of this study clearly show that Ca2+ channel antagonists inhibited both 
tumor cell growth (Figs. 4.3 - 4.6 and 4.8) and an agonist-induced release of Ca2+ from 
the internal stores (Figs. 4.18 - 4.21) in human brain tumor cell lines. Thus, these 
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results suggest that the inhibitory effects of Ca2+ channel antagonists on tumor cell 
growth may be due to their blocking actions on the release of Ca2+ from the internal 
stores during cell proliferation. 
A remaining important question is how Ca2+ channel antagonists can block an 
agonist-induced release of Ca2+ from the internal stores. Although these drugs may have 
many sites of action, possible interactive sites can be divided into five different 
categories: (i) the plasma membrane receptors of growth factors (e.g. carbachol or 
serum factors); (ii) G-proteins, especially Gq, which couple the membrane receptors with 
phospholipase C; (iii) phospholipase C (PLC); (iv) IP3-activated ca2+ channels in the 
endoplasmic reticulum (ER); (v) indirect mechanism including the interaction with plama 
membrane K+ channels. 
The allosteric interaction of Ca2+ channel antagonists, particularly, verapamil and 
diltiazem, with the muscarinic receptors has been previously described in many different 
cellular systems (Arita et al., 1991; Gerry et al., 1987; Katayama et al., 1987; Potter 
et al., 1989; Waelbroeck et al., 1984). The binding of platelet activating factor to 
human platelets (Valone, 1987) and human neutrophil granulocytes (Filep and Foldes-
Filep, 1990) has also been shown to be inhibited by Ca2+ channel antagonists (verapamil 
and diltiazem). Thus, the blockade of carbachol-binding to its receptors by Ca2+ channel 
antagonists, at least verapamil and diltiazem, seems to be a likely mechanism of their 
inhibitory action on the carbachol-induced release of Ca2+ from internal stores shown in 
Figs. 4.18 and 4.19. However, the interaction of Ca2+ channel antagonists with the 
receptors of other serum growth factors has not been previously described. The 
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interaction of these antagonists with G-proteins and phospholipase C is also unknown. 
Homa et al. found that verapamil abolished a thrombin-induced increased phosphatidic 
acids in rabbit platelets, and proposed that this effect of verapamil may modify 
phosphoinositide metabolism. However, the exact mechanism of this action of verapamil 
has not been described. 
The possibility that Ca2+ channel antagonists may block IPractivated Ca2+ channels 
in the ER seems not to be a likely mechanism since Shah and Pant, using microsomes 
isolated from the rat brain, showed that the IP3-induced Ca2+ release was insensitive to 
a variety of Ca2+ channel blockers including verapamil and nifedipine (Shah and Pant, 
1988). However, Ca2+ channel antagonists may affect indirectly IPrinduced Ca2+ release 
through their inhibition of calmodulin (CaM) action. Of particular interest, CaM 
antagonists have shown to inhibit IP3-stimulated Ca2+ mobilization, and thus, CaM has 
been suggested to be tightly associated with the intracellular membrane mechanism 
coupling IP3 receptors to Ca2+ release channels (Hill et al., 1988). Moreover, some 
Ca2+ channel antagonists are known to bind CaM and inhibit CaM functions (Walsh et 
al., 1988; Zimmer and Hofmann, 1987). 
Other indirect mechanisms may be possibly involved. The electrophysiological 
experiments have revealed that verapamil at concentration less than 10 µM, can inhibit 
voltage-dependent K+ currents found in T lymphocytes (Decoursey et al., 1985), snail 
neurons (Kostyuk et al., 1975) and small cell lung carcinoma cells (Pancrazio et al., 
1991). Since in most cells K+ channel activities have been shown to be directly involved 
in the regulation of the membrane potential (Amigorena et al., 1990; Aronson, 1992; 
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Cahalan and Lewis, 1990; Curran et al., 1992; Wu and Barish, 1992), the inhibition of 
K+ channels can induce an alteration of the membrane potential. Moreover, prior 
depolarization of plasma membrane potential has been demonstrated to reduce an agonist-
induced Ca2+ release from intracellular stores in the promyelocytic cell line HL-60 (Pittet 
et al., 1990) and human neutrophiles (Di Virgilio et al., 1987). In these results the 
inhibition of Ca2+ release by plasma membrane depolarization is paralleled and probably 
caused, by the inhibitory effect on IP3 formation (Pittet et al., 1990). The mechanism 
by which depolarization inhibits IP3 formation and, thus, Ca2+ mobilization can only be 
speculated. Alteration of the plasma membrane potential may easily affect protein 
mobility, the lipid bilayer organization or the activity of various transmembrane enzymes 
(Pittet et al., 1990). Thus, possible mechanisms may include changes in the accessibility 
of phosphatidylinositol (4,5)-bisphosphate to phospholipase C or uncoupling an important 
regulatory subunit, such as a G protein, from the phospholipase C. 
Intracellular cyclic AMP may be considered to be a possible mediator of the action 
of ca2+ channel blockers. Increased intracellular cyclic AMP has been shown to inhibit 
inositol phospholipid hydrolysis and this effect appeared to be associated with protein 
kinase A-mediated phosphorylation of phospholipase C--yl (Aiava et al., 1992). Some 
ca2+ channel blockers are known to inhibit CaM-dependent enzymes, particulary, cyclic 
AMP phosphodiesterase which degrades cylic AMP to adenosine nucleoside and 
inorganic phosphate (Walsh et al., 1988; Zimmer and Hofmann, 1987). Thus, Ca2+ 
channel antagonists may increase intracellular cyclic AMP concentration and ultimately 
reduce IP3 generation through the inhibition of inositol phospholipid hydrolysis. 
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Finally, Protein kinase C (PKC) may be involved in Ca2+ channel antagonist-induced 
inhibition of Ca2 + release from internal stores. Felodipine, a dihydropyridine Ca2 + 
channel blocker, has been shown to enhance both the rate and extent of P4 7 
phosphorylation by PKC (Sutherland and Walsh, 1989). This activation of PKC was 
dependent upon the presence of phospholipids but did not require diacylglycerol. In 
addition, phorbol esters, direct activators of PKC, have been shown to inhibit agonist-
induced phosphoinositide hydrolysis in various cell types such as the rat hippocampal 
slices (Labarca et al., 1984; Schoepp and Johnson, 1988), cultured vascular smooth 
muscle cells (Brock et al., 1985), hamster vas deferens smooth muscle cells (Leeb-
Lundberg et al., 1985) and Chinese hamster ovary (CHO) cells (Aramori and Nakanishi, 
1992). These effects of phorbol esters ultimately resulted in the inhibition of agonist-
induced Ca2+ mobilization, and this effect appeared to occur via activation of PKC 
(Berridge, 1987; Drummond and Macintyre, 1985; He et al., 1988; Nishizuka, 1986). 
Of particular interest, PKC has also been shown to inhibit insulin receptor-mediated 
tyrosine kinase activation (Bollag et al., 1986). Thus, Ca2+ channel antagonist-induced 
blockade of intracellular Ca2+ mobilization may be possibly due to their modulatory 
effect on PKC. The whole cascades of these events which may be induced by Ca2+ 
channel antagonists are summarized diagramatically in Fig. 4.24. 
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Fig. 4.24. Proposed inhibitory mechanisms of Ca2+ channel antagonists in tumor cell 
growth. This figure shows the signal transduction pathways of growth factors and carbachol-
inducing tumor cell proliferation. In general, the stimulation of growth factor receptors can 
phosphorylate and then activate PLC-)' by an intrinsic receptor tyrosine kinase. The stimulation 
of muscarinic receptors by carbachol can evoke PLC activation through the interaction with G-
proteins (specifically, GP). PLC-)' and PLC degrade PIP2 into DAG and IP3 • IP3 binding to the 
receptors on the ER membrane can open IP3-sensitive Ca2 + channels, and DAG can activate PKC. 
An increased intracellular Ca2+ can ultimately lead to tumor cell proliferation with the 
cooperation of other signals. This figure also shows a possible intervening step in these pathways 
by Ca2+ channel antagonists. Abbrevations used: CCAs, Ca2+ channel antagonists; GFs, growth 
factors; Carb, carbachol; R, receptor; RTK, receptor tyrosine kinase; PLC, phospholipase C; 
PLC-'Y, phospholipase C-'Y; Gp, GTP binding protein; PIP2, phosphatidylinositol 4,5-bisphosphate; 
IP3 , inositol 1,4,5-triphosphate; DAG, diacylglycerol; PKC, protein kinase C; cAMP, cyclic 
adenosine 3',5'-monophosphate; PDE, cyclic AMP phosphodiesterase; CaM, calmodulin; E,,,, 
membrane potential; [K+]j, intracellular K+ concentration; [Ca2 +];, intracellular Ca2 + 
concentration; IP3 R, IP3 receptor Ca2 + channel; ER, endoplasmic reticulum; PM, plasma 
membrane. 
CHAPTER V 
MECHANISM OF POTASSIUM CHANNEL MODULATOR-INDUCED 
INHIBITION OF TUMOR CELL GROWTH 
A. Introduction 
Cell proliferation induced by growth factors and mitogens, has been recognized to 
be initiated by transient changes in intracellular cation concentrations such as Ca2+, H+ 
and Na+ (Geck and Bereiter-Hahn, 1991; Mendoza, 1988; Moolenaar et al., 1981; 
Prasad et al., 1987). Moreover, several pieces of evidence suggest that K+ channels are 
directly or indirectly involved in the initiation of cell proliferation (Decoursey et al., 
1984; Deutsch, 1990). Various mitogens have been shown to activate K+ channels. T 
cell mitogen, concanavalin A (ConA), increases the number of K+ channels in murine 
T lymphocytes (Decoursey et al., 1987). In a murine noncytolytic T lymphocyte clone, 
L2, voltage-sensitive K+ conductance is increased during interleukin 2 (IL2)-stimulated 
proliferation (Lee et al., 1986). Ca2+ -activated K+ channels seem also to be involved 
in the process of mitogen-induced cell proliferation as shown in mouse fibroblasts 
(Kusano and Gainer, 1991), rat thymic lymphocytes (Mahaut-Smith and Mason, 1991) 
and ras-transformed fibroblasts (Rane, 1991). Moreover, many studies with K+ 
channel blockers have demonstrated a reasonable quantitative agreement between block 
of K+ currents and inhibition of cell proliferation. Amigorena and coworkers have shown 
that K+ channel blockers such as TEA, quinine and verapamil suppressed both K+ 
current and DNA synthesis in murine B lymphocytes (Amigorena et al., 1990). Similar 
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results have been found in neuroblastoma cells (Rouzaire-Dubois and Dubois, 1990; 
Rouzaire-Dubois and Dubois, 1991), rat malignant lymphocytes, Nb2 cells (Cukierman, 
1992), human peripheral blood lymphocytes (Price et al., 1989), rat astrocytes (Ohira 
et al., 1991), retinal glial cells (Puro et al., 1989) and Schwann cells (Chiu and Wilson, 
1989). 
However, the relationship between cell proliferation and K+ channel activity is not 
obvious (Deutsch, 1990; Gallin, 1991; Gardner, 1990), although their correlationship has 
been successively attributed to a Ca2+ influx through K+ channels (Kuno et al., 1986), 
the maintenance of a hyperpolarized resting membrane potential and, thus, probably 
enhancing Ca2+ influx by maintaining the electrical gradient for Ca2+ ions (Amigorena 
et al., 1990; Cahalan and Lewis, 1990; Chiu and Wilson, 1989) or a regulation of cell 
volume and intracellular Na+ concentration (Rouzaire-Dubois and Dubois, 1990). 
Membrane potential (Em) changes induced by various mitogens have been detected, 
particularly in lymphocytes (Gelfand et al., 1987; Kiefer et al., 1980; Mahaut-Smith and 
Mason, 1991). In addition to these observed Em changes, a concomitant rise in 
intracellular Ca2+ has been reported following mitogenic stimulation (Hesketh et al., 
1983; Tatham et al., 1986; Tsien et al., 1982). In general, membrane hyperpolarization 
followed by depolarization can be observed with the treatment of mitogens and these Em 
changes are due to the activation of Ca2+ -dependent K+ channels and inward Na+ 
movement, respectively. Alteration of the K+ channel activity may change the Em and, 
in tum, the alterated Em can affect other ion movements through the changes of 
transmembrane electrical gradients of these ions. Thus, interrelationship between the 
95 
increased intracellular Ca2+ concentration and the K+ channel activities may occur, which 
would be an important cue for solving the mechanisms of action of K+ channel 
antagonists in the inhibition of cell proliferation. However, the exact role of the K+ 
channel activity in the intracellular Ca2+ regulation is essentially unknown. 
The experiments in this chapter were designed to elucidate the mechanisms of action 
of K+ channel modulators in the inhibition of tumor cell growth. The data descibe the 
effects of the K+ channel modulators on tumor cell growth and a growth factor-induced 
increased intracellular Ca2+ concentration. The K+ channel modulators effectively 
inhibited the tumor cell growth and blocked an agonist-induced increased intracellular 
Ca2+ concentration. The results suggest that inhibitory actions of the K+ channel 
modulators in tumor cell growth may be due to their modulatory effects on an agonist-
induced alteration of intracellular Ca2+. 
B. Results 
Inhibition of Tumor Cell Growth by High Extracellu/o,r Potassium 
Dependence of tumor cell growth on the extracellular K+ concentration was 
investigated. In these experiments the sum of NaCl and KCl concentrations in the 
growth medium was made 122 mM by substituting NaCl with an equivalent amount of 
KCl in order to maintain a constant osmolarity. Fig. 5.1 shows the effect of various 
concentrations of extracellular K+ on the growth of U-373 MG human astrocytoma and 
SK-N-MC human neuroblastoma cell lines. The results indicate that these tumor cell 
growth was inhibited by increasing the extracellular K+ in a dose-dependent manner. 
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Fig. 5.1. Effect of high extracellular K+ on the growth of U-373 MG human 
astrocytoma (closed circle) and SK-N-MC human neuroblastoma (open inverted 
triangle) cell lines. The cells were grown in MEM supplemented with 10% FBS in the 
absence or in the presence of various concentrations of K+ in the culture medium. The 
cell number was counted 2 days after K+ treatment. The results were expressed as a 
percent change of the number of the cells obtained in the culture medium containing 
normal K+ concentration (5.4mM). The data points represent the mean value of at least 
four replicate dishes with bars indicating SEM. 
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These results suggest that tumor cell proliferation may be regulated by the alteration of 
the membrane potential since increased extracellular K + concentration is known to 
depolarize plasma membrane potential (Pittet et al., 1990). 
Membrane depolarization has been shown to reduce agonist-induced Ca2+ influx 
across the plasma membrane in nonexcitable cells from which voltage-dependent Ca2+ 
channels are absent (Di Virgilio et al., 1987; Penner et al., 1988; Pittet et al., 1990). 
The inhibition of Ca2+ influx could be due, at least in part, to a decreased Ca2+ 
electrochemical gradient. However, since in the tumor cells which were used in this 
study, Ca2+ influx appeared not to be involved in the cell proliferation as described in 
Chapter 4, high extracellular K+ -induced inhibition of these tumor cell growth may be 
not due to its effect on Ca2+ influx. Recently, the alteration of plasma membrane 
potential has been shown to affect on agonist-induced second messenger generation 
including cytosolic free Ca2+ and IP3, in HL-60, the promyelocytic cell line (Pittet et al., 
1990). Thus, the effects of high extracellular K+ on agonist-induced release of Ca2+ 
from the internal stores were investigated in order to elucidate the mechanism of its 
action on the regulation of tumor cell growth. 
Potassium Channel Modulator-Induced Inhibition of Tumor Cell Gowth 
In order to see the involvement of K+ channels in tumor cell growth, typical K+ 
channel antagonists, tetraethylammonium chloride (TEA) and 4-aminopyridine (4-AP), 
and diazoxide, known as a K+ channel opener, were used in these experiments. Figs. 
5.2 and 5.3 show the effects of these K+ channel modulators on the growth of U-373 
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Fig. 5.2. Effect of K+ channel modulators on the growth of U-373 MG human 
astrocytoma cell lines. The cells were grown in MEM supplemented with 10% PBS in 
the absence or in the presence of various concentrations of TEA (closed circle), 4-AP 
(open inverted triangle) or diazoxide (closed inverted triangle) in the culture medium. 
The cell number was counted 2 days after drug treatment. The results were expressed 
as a percent change of the number of the cells obtained in the absence of the drug. The 
data points represent the mean value of at least four replicate dishes with bars indicating 
SEM. 
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Fig. 5.3. Effect of K+ channel modulators on the growth of SK-N-MC human 
neuroblastoma cell lines. The cells were grown in MEM supplemented with 10% PBS 
in the absence or in the presence of various concentrations of TEA (closed circle), 4-AP 
(open inverted triangle) or diazoxide (closed inverted triangle) in the culture medium. 
The cell number was counted 2 days after drug treatment. The results were expressed 
as a percent change of the number of the cells obtained in the absence of the drug. The 
data points represent the mean value of at least four replicate dishes with bars indicating 
SEM. 
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MG human astrocytoma and SK-N-MC human neuroblastoma cell lines, respectively. 
The results illustrate that these K + channel modulators induced the inhibition of tumor 
cell growth in a dose-dependent fashion. Interestingly, diazoxide was the most effective, 
and followed by 4-AP and TEA in both tumor cell lines. 
These growth-inhibitory effects of K+ channel modulators may be attributed either 
to the inhibition of cell proliferation or to cell cytotoxicity. Moreover, these two 
possibilities can not be differentiated by only the measurement of the number of cells as 
shown in Figs. 5.2 and 5.3. Thus, the cytotoxicity assay was made using trypan blue 
exclusion method (see Chapter 3 for the method description in detail). Figs. 5.4 and 5.5 
show the effects of K+ channel modulators on the cell viability of U-373 MG human 
astrocytoma and SK-N-MC human neuroblastoma cell lines, respectively. The results 
indicate that these drugs did not induce cytotoxicity in both cell lines. Therefore, the 
growth-inhibitory effects of K+ channel modulators may be due to their suppression of 
tumor cell proliferation. 
The inhibition of tumor cell proliferation by K+ channel modulators can be explained 
by several mechanisms. First, in lymphocytes an early mitogen-induced increased 
intracellular Na+ concentration has been shown to be a necessary and sufficient signal 
for the rejoining of DNA strand breaks, an event which must occur before the 
proliferating lymphocytes can replicate their DNA (Prasad et al., 1987). The increased 
intracellular Na+ would only be effective if the Na+ influx is accompanied by an efflux 
of K+. If the membrane pathway of K+ (e.g. K+ channels) is closed or blocked, the 
entry of Na+ into the cell would be accompanied by an influx of water and/or ci-, 
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Fig. 5.4. No cytotoxic effect of K+ channel modulators on U-373 MG human 
astrocytoma cell line. The cells were grown in MEM supplemented with 10 % FBS in 
the absence or in the presence of the drugs in the culture medium. Cell cytotoxicity was 
assayed by trypan blue extrusion method 2 days after drug treatment. The results were 
expressed as a percent change of the number of dead cells obtained in the absence of the 
drug. Each column represents the mean value of four replicates with bars indicating 
SEM. The data were compared using one way ANOVA and Student-Newman-Keul's test 
for individual comparison. 
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Fig. 5.5 No cytotoxic effect of K+ channel modulators on SK-N-MC human 
neuroblastoma cell line. The cells were grown in MEM supplemented with 10% FBS 
in the absence or in the presence of the drugs in the culture medium. Cell cytotoxicity 
was assayed by trypan blue extrusion method 2 days after drug treatment. The results 
were expressed as a percent change of the number of dead cells obtained in the absence 
of the drug. Each column represents the mean value of four replicates with bars 
indicating SEM. The data were compared using one way ANOV A and Student-Newman-
Keul 's test for individual comparison. 
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resulting in swelling of the cell and dilution of intracellular Na+, whose concentration 
would remain more or less constant (Rouzaire-Dubois and Dubois, 1990). Thus, the 
blockade of K+ channels can inhibit a mitogen-induced increased intracellular Na+ 
concentration, resulting in the inhibition of cell proliferation. However, the role of 
increased intracellular Na+ concentration has not been described in these tumor cells. 
Therefore, in order to test this possibility, the effects of veratridine, a Na+ ionophore, 
and tetradotoxin (TTX), a voltage-sensitive Na+ channel blocker, on these tumor cell 
growth were investigated and the results are shown in Figs. 5.6. and 5.7. These results 
indicate that both veratridine and TIX did not induce a significant alteration of the 
growth of these tumor cells. Thus, these results suggest that increased intracellular Na+ 
concentration is not an important signal for cell proliferation in these tumor cells. These 
results further suggest that the growth-inhibitory effects of K+ channel modulators shown 
in this study, are not due to their inhibition of mitogen-induced increased intracellular 
Na+ concentration. 
Second, Chandy et al. have suggested that in T lymphocytes Ca2+ entry is required 
for cell proliferation and that this Caz+ entry may occur through the voltage-dependent 
K+ channels (Chandy et al., 1984). Thus, the blockade of these K+ channels may induce 
the inhibition of Ca2+ entry, resulting in the inhibition of cell proliferation. However, 
since in the tumor cells used in this study, Ca2+ influx appeared to be not necessary for 
their growth, this possibility may be excluded. 
Lastly, since in these tumor cell lines the release of Ca2+ from the internal stores 
appeared to be an important signalling mechanism of growth factors in cell proliferation 
104 
140 
U-373 MG human astrocytoma 
120 ----------~~----------~ ........ 0 ~ 
...._; 
' 
, 
~ 100 
0 
u 
~ 
0 
~ 80 
• TTX 
\l veratridine 
Drug Concentration (M) 
Fig. 5.6. Effect of veratridine and TTX on the growth of U-373 MG human 
astrocytoma cell lines. The cells were grown in MEM supplemented with 10% PBS in 
the absence or in the presence of various concentrations of TTX (closed circle) and 
veratridine (open inverted triangle) in the culture medium. The cell number was counted 
2 days after drug treatment. The results were expressed as a percent change of the 
number of the cells obtained in the absence of the drug. The data points represent the 
mean value of at least four replicate dishes with bars indicating SEM. 
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Fig. 5.7. Effect of veratridine and TTX on the growth of SK-N-MC human 
neuroblastoma cell lines. The cells were grown in MEM supplemented with 10% PBS 
in the absence or in the presence of various concentrations of TTX (closed circle) and 
veratridine (open inverted triangle) in the culture medium. The cell number was counted 
2 days after drug treatment. The results were expressed as a percent change of the 
number of the cells obtained in the absence of the drug. The data points represent the 
mean value of at least four replicate dishes with bars indicating SEM. 
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(decribed in Chapter 4), the growth-inhibitory effects of K+ channel modulators may 
result from the inhibition of this Ca2+ mobilization. In order to test this possibility, the 
effects of K+ channel modulators on agonist-induced intracellular Ca2+ mobilization were 
investigated. 
No Voltage-Dependent Calcium Channels Are Present in U-373 MG Human 
Astrocytoma and SK-N-MC Human Neurobla.stoma Cell Unes 
In order to test the existence of voltage-dependent Ca2+ channels in these tumor cells, 
the intracellular Ca2+ concentration was monitored under the condition of the high 
extracellular K+ -induced membrane depolarization. This manipulation did not induce 
the increased intracellular Ca2+ concentration in both cell lines as shown in Figs. 5.12 
and 5.13. The treatment of Bay K-8644, a Ca2+ channel agonist, and high extracellular 
K+ also did not induce the increased intracellular Ca2+ concentration (data not shown). 
These results suggest that these tumor cells do not have voltage-dependent Ca2+ channels. 
Inhibition of Agonist-Induced Release of Calcium from the Internal Stores by 
Potassium Channel Modula.tors 
Since the intracellular Ca2+ mobilization from the internal stores appeared to be 
involved in these tumor cell proliferation as described in Chapter 4, the effects of K+ 
channel modulators including high extracellular K+ on an agonist-induced increased 
intracellular Ca2+ concentration were examined. In these experiments carbachol (Carb) 
and serum were used as Ca2+ mobilizing agents in U-373 MG human astrocytoma and 
SK-N-MC human neuroblastoma cell lines, respectively. Since the resuspending medium 
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containing 0 Ca2+ was used, a agonist-induced increased intracellular Ca2+ concentration 
may result from the internal store release. The concentrations of K+ channel modulators 
were chosen on the basis of their effects on tumor cell growth. 
Figs. 5. 8 shows single representative traces of net increases of intracellular Ca2+ 
concentrations induced by Carb and the effects of pretreatment of K+ channel modulators 
in U-373 MG human astrocytoma cell line. Fig. 5.9 depicts the effects of these drugs 
on serum-induced responses in SK-N-MC human neuroblastoma cell line. For 
quantatitive comparison, percent changes of net increments of intracellular Ca2+ 
concentrations in the pretreatment of K+ channel modulators compared to Carb or serum-
induced Ca2+ increases in the absence of these drugs were calculated and are displayed 
in Figs. 5 .10 and 5 .11. The bars in these figures represent the SEM obtained from at 
least four different measurements. These results demonstrate that K+ channel modulators 
induced statistically significant differences compared to the effect of an agonist alone in 
both cell lines. These results further suggest that their growth-inhibitory effects may be 
due to the blockade of agonist-induced intracellular Ca2+ mobilization in these tumor 
cells. 
Potassium Channel Modulators do not Affect the Basal, Free Cytosolic Calcium 
Concentrations in Tumor Cells 
If K+ channel modulators can alter the basal, free cytosolic Ca2+ concentrations, an 
agonist-induced intracellular Ca2+ mobilization may be affected by these changes which 
can result in the alteration of the electrochemical gradient for Ca2+ ion movements from 
the lumen of the ER to the cytosol. In order to test this possibility, the effects of K+ 
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Fig. 5.8. Effect of high extracellular K+ or K+ channel modulators on carbachol 
(0.SmM)-induced intracellular Cai+ mobilization in U-373 MG human astrocytoma 
cell line. Aliquots of 5xl06 cells/ml were incubated with 2µM of Fura-2-AME for 60 
minutes at room temperature. The cells were washed, resuspended in the buffer solution 
containing 0 Ca2+ and transferred to a quartz cuvette for fluorescence measurements. 
The data represent net increases of intracellular Cai+ concentration with time. The arrow 
shows the time point for the addition of carbachol. KCl or K+ channel modulators were 
treated for 3 minutes before starting the experiment. 
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Fig. 5.9. Effect of high extracellular K+ or K+ channel modulators on serum (2%)-
induced intracellular Caz+ mobilization in SK-N-MC human neuroblastoma cell line. 
Aliquots of 5xl06 cells/ml were incubated with 2µM of Fura-2-AME for 60 minutes at 
room temperature. The cells were washed, resuspended in the buffer solution containing 
0 Ca2+ and transferred to a quartz cuvette for fluorescence measurements. The data 
represent net increases of intracellular Ca2+ concentration with time. The arrow shows 
the time point for the addition of serum. KCl or K+ channel modulators were treated for 
3 minutes before starting the experiment. 
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Fig. 5.10. Quantitative changes of carbachol (0.8mM)-induced intracellular Ca2+ 
mobilization by high extracellular K+ or K+ channel modulators in U-373 MG 
human astrocytoma cell line. Aliquots of 5x1CJ6 cells/ml were incubated with 2µM of 
Fura-2-AME for 60 minutes at room temperature. The cells were washed, resuspended 
in the buffer solution containing 0 Cai+ and transferred to a quartz cuvette for 
fluorescence measurements. The results were expressed as a percent change of the 
increased intracellular Ca2+ concentration induced by the drugs compared to carbachol 
alone. Each column represents the mean value of at least five replicates with bars 
indicating SEM. The data were compared using one way ANOVA and Student-Newman-
Keul's test for individual comparison. (*p<0.05 compared to carbachol alone) 
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Fig. 5.11. Quantitative changes of serum (2%)-induced intracellular Ca2+ 
mobilization by high extracellular K+ or K+ channel modulators in SK-N-MC 
human neuroblastoma cell line. Aliquots of 5xl06 cells/ml were incubated with 2µM 
of Fura-2-AME for 60 minutes at room temperature. The cells were washed, 
resuspended in the buffer solution containing 0 Ca2+ and transferred to a quartz cuvette 
for fluorescence measurements. The results were expressed as a percent change of the 
increased intracellular Caz+ concentration induced by the drugs compared to serum alone. 
Each column represents the mean value of at least five replicates with bars indicating 
SEM. The data were compared using one way ANOVA and Student-Newman-Keul's test 
for individual comparison. (*p<0.05 compared to serum alone) 
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channel modulators on the basal levels of intracellular ca2+ concentrations were 
investigated. The results are shown in Figs. 5.12 and 5.13. 
These results illustrate that K+ channel modulators did not induce the significant 
alteration of the basal levels of intracellular Ca2+ concentrations. Thus, the blockade of 
agonist-induced intracellular Ca2+ increases by these drugs may be not due to the 
alteration of basal, free cytosolic Ca2+ concentration. These results further suggest that 
K+ channel modulators may exert their effects only in the stimulatory state of the cells. 
C. Discussion 
Proposed Mechanism of lnhibiJory Effects of Potassium Channel Modulators on Tumor 
Cell Growth 
High extracellular K+ and some K+ channel modulators inhibited tumor cell growth 
as shown in Figs. 5.1 - 5.3. These drugs appeared to be non-cytotoxic to the tumor cells 
used in this study (Figs. 5.4 and 5.5) and, thus, their growth-inhibitory effects are due 
to the blockade of cell proliferation. In addition to their effects on the tumor cell 
growth, K+ channel modulators evoked the inhibition of growth factor-induced increased 
intracellular ca2+ concentrations as shown in Figs 5. 8 - 5 .11. These Ca2+ increases 
resulted from the internal store release. Thus, apparent correlationship between these 
two effects of K+ channel modulators suggests that the mechanism of their inhibitory 
action on tumor cell growth may be due to the blockade of growth factor-induced Ca2+ 
mobilization. 
A remaining question is how K+ channel modulators can inhibit agonist-induced Ca2+ 
mobilization from internal stores. These K+ channel modulators are assumed to act only 
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Fig. 5.12. No effect of high extracellular K+ or K+ channel modulators on basal, 
free cytosolic Cal+ concentration in U-373 MG human astrocytoma cell line. 
Aliquots of 5xl06 cells/ml were incubated with 2µM of Fura-2-AME for 60 minutes at 
room temperature. The cells were washed, resuspended in the buffer solution containing 
0 Ca2 + and transferred to a quartz cuvette for fluorescence measurements. The results 
were expressed as a percent change of intracellular Ca2+ concentration induced by the 
drugs compared to control. Each column represents the mean value of at least five 
replicates with bars indicating SEM. The data were compared using one way ANOV A 
and Student-Newman-Keul's test for individual comparison. 
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Fig. 5.13. No effect of high extracellular K+ or K+ channel modulators on basal, 
free cytosolic Ca2+ concentration in SK-N-MC human neuroblastoma cell line. 
Aliquots of 5xl06 cells/ml were incubated with 2µM of Fura-2-AME for 60 minutes at 
room temperature. The cells were washed, resuspended in the buffer solution containing 
0 Ca2+ and transferred to a quartz cuvette for fluorescence measurements. The results 
were expressed as a percent change of intracellular Ca2+ concentration induced by the 
drugs compared to control. Each column represents the mean value of at least five 
replicates with bars indicating SEM. The data were compared using one way ANOV A 
and Student-Newman-Keul's test for individual comparison. 
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on the extracellular sites of the plasma membrane since they do not readily penetrate the 
membrane due to their hydrophilic molecular structures (Palade et al., 1989). Therefore, 
the main sites of action of these drugs are plasma membrane K+ channels and/or the 
receptors of Ca2+ - mobilizing agonists. Of particular interest, 4-AP appeared to bind the 
allosteric sites of muscarinic receptors in rabbit hippocampal membrane fractions (Potter 
et al., 1989). Thus, the inhibition of the carbachol-induced intracellular ca2+ 
mobilization by these K+ channel modulators at least 4-AP, may be due to the inhibition 
of the binding of carbachol to its receptors. 
These drugs may also induce the alteration of membrane potential and intracellular 
K+ concentration through the modulation of plasma membrane K+ channel activities. 
Plasma membrane depolarization has been shown to reduce agonist-induced intracellular 
Ca2+ mobilization and in parallel IP3 generation in human neutrophils (Di Virgilio et al., 
1987) and HL-60 cells (Pittet et al., 1990). Although in the present experiments the 
effects of these drugs on agonist-induced IP3 generation were not seen, the inhibition of 
agonist-induced Ca2+ mobilization by these drugs may be due to their effects on agonist-
induced IP3 generation. However, the exact role of membrane potential changes in 
agonist-induced IP3 generation and ultimate Ca2+ mobilization is unknown, and can only 
be speculated. The alteration of the membrane potential may change the stability and 
organization of plasma membrane lipids and proteins (Matthew, 1985). Thus, these 
electrostatic effects may be expected to alter membrane enzyme activities, the interaction 
of these enzymes with their substrates and/or protein-protein interactions. Moreover, the 
activities of many enzymes associated with the plasma membrane, appeared to be 
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dependent on the surface membrane potential as shown in phosphocholine 
cytidylyltransferase (Cornell, 1991), protein kinase C (Epand and Lester, 1990; Lester 
et al. , 1990), apocytochrome c (Berkhout et al. , 1987) and synapsin (Benfenati et al., 
1989). Therefore, if membrane potential changes somehow induce the altered activities 
of phospholipase C (PLC), these changes can result in the altered IP3 generation and, 
thus, the altered Ca2+ mobilization during agonist stimulation. Other possibilities may 
include changes in the accessibility of substrate (e.g. PIP2), to the PLC, or uncoupling 
a regulatory subunit of G- protein from the PLC. 
Interestingly, the same inhibitory effects of K+ channel antagonists such as TEA and 
4-AP, and K+ channel activator such as diazoxide, on the tumor cell growth and agonist-
induced Ca2+ mobilization were observed in the present study. If these agents simply 
acted by varying intracellular K+ concentrations, diazoxide would be expected to have 
the opposite effect of K+ channel antagonists, i.e. increased tumor cell growth and 
agonist-induced Ca2+ mobilization. Notable in this regard, Palade and his associates 
recently found that in canine microsomes, IP3-induced Ca2+ release from the microsomes 
appeared to be dependent on the presence of K+ in the medium (Palade et al., 1989). 
Although a gradual reduction of K+ concentration induced a parallel inhibition of IP3-
induced Ca2+ mobilization from the microsomes, the increase of K+ permeability by the 
treatment of valinomycin, a K+ ionophore, did not significantly affect on the IP3-induced 
Ca2+ release. Thus, these results may suggest that K+ channel blockers which can induce 
an increased intracellular K+ concentration, would not have an effect on agonist-induced 
Ca2+ mobilization. However, diazoxide-induced reduction of cytoplasmic K+ 
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concentration through activation of plasma membrane K+ channels would result in the 
inhibition of agonist-induced Ca2+ mobilization. 
Taken together, K+ channel modulators may affect an agonist-induced Ca2+ 
mobilization from the internal stores by acting on at least two different steps, e.g. 
generation of IP3 and Ca2+ release from internal stores. Interestingly, these two steps 
may be inversely regulated by a K+ channel modulator. However, K+ channel blockers 
seem to be more effective in the step of agonist-induced IP3 generation, on the other hand 
K+ channel opener may predominantly affect the Ca2+ releasing step. These speculations 
are based on the assumption that diaxoxide may have a stimulatory effect on K+ channels 
in these tumor cells. However, the effect of diazoxide on K+ channels has not been 
described in these tumor cells and remains to be investigated. 
In conclusion, the inhibition of tumor cell growth by high extracellular K+ and K+ 
channel modulators may be due to their blocking actions on agonist-induced Ca2+ 
mobilization from the internal stores through the alteration of membrane potential and 
intracellular K+ concentrations. These changes may alter agonist-induced IP3 generation 
and/or Ca2+ release from the stores. The summarized possible mechanisms of action of 
these drugs are shown diagramatically in Fig. 5.13. 
KC As 
K+ channels 
I Tumor Cell Growth I 
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Fig. 5.14. Proposed inhibitory mechanisms of high extracellular K+ or K+ channel 
modulators in tumor cell growth. This figure shows the signal transduction pathways 
of growth factors and carbachol-inducing tumor cell proliferation. In general, the 
stimulation of growth factor receptors can phosphorylate and then activate PLC-'Y by an 
intrinsic receptor tyrosine kinase. The stimulation of muscarinic receptors by carbachol 
can evoke PLC activation through the interaction with G-proteins (specifically, Gp). 
PLC-'Y and PLC degrade PIP2 into DAG and IP3• IP3 binding to the receptors on the ER 
membrane can open IP3-sensitive Ca2+ channels, and DAG can activate PKC. An 
increased intracellular Ca2+ can ultimately lead to tumor cell proliferation with the 
cooperation of other signals. This figure also shows a possible intervening step in these 
pathways by high extracellular K+ or K+ channel modulators. Abbrevations used: 
KCAs, K+ channel antagonists; GFs, growth factors; Carb, carbachol; R, receptor; RTK, 
receptor tyrosine kinase; PLC, phospholipase C; PLC-'Y, phospholipase C-'Y; GP, GTP 
binding protein; PIP2, phosphatidylinositol 4,5-bisphosphate; IP3 , inositol 1,4,5-
triphosphate; DAG, diacylglycerol; Em, membrane potential; [K+]i, intracellular K+ 
concentration; [Ca2+]i, intracellular Ca2+ concentration; IP3 R, IP3 receptor Caz+ channel; 
ER, endoplasmic reticulum; PM, plasma membrane. 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
Many studies suggest that the increased intracellular Ca2+ concentration is a critical 
event in the proliferative signalling mechanism of growth factors. Moreover, plasma 
membrane Ca2+ and K+ channels are involved in the regulation of intracellular Caz+ 
homeostasis. However, the mechanism of the involvement of these ion channels in tumor 
cell growth remains controversial. Thus, the major objective of this disseration was to 
examine the roles of ion channels in nervous system tumor cell growth. Specifically, 
using U-373 MG human astrocytoma and SK-N-MC human neuroblastoma cell lines as 
model systems, three questions were addressed by this dissertation. 1) What are the 
effects of Ca2+ and K+ channels-regulating drugs on these tumor cell growth? 2) What 
are the characteristics and sources of increased intracellular Ca2+ concentration elicited 
by growth factors in these tumor cell lines? 3) Does a correlation exist between the 
effects of these drugs on tumor cell growth and intracellular Ca2+ concentration changes 
induced by growth factors? 
In order to explore the first question, the effects of various Ca2+ and K+ channel 
agonists and antagonists on tumor cell growth were investigated. Tumor cell growth was 
assessed by counting the number of cells using a hemocytometer. The results were 
described in Chapter 4 and 5 in this dissertation. The findings are: 
1) Prototypic voltage-sensitive Ca2+ channel antagonists, verapamil, nifedipine and 
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diltiazem, and inorganic Ca2+ channel blockers, Ni2+ and Co2+, induced the inhibition 
of the growth of these tumor cells in a dose-dependent manner. 
2) Bay K-8644, a Caz+ channel agonist, did not induce a significant alteration of the 
growth of these tumor cells. 
3) SK&F 96365 which is known as a receptor-operated Ca2+ channel antagonist, very 
effectively inhibited tumor cell growth. 
4) K+ channel antagonists such as tetraethyl ammonium chloride and 4-aminopyridine, 
inhibited tumor cell growth in a dose-related fashion. 
5) Diazoxide, a K+ channel activator, also induced the inhibition of tumor cell growth. 
6) In addition to ion channel modulators, these tumor cells responded to changes of the 
extracellular concentrations of Ca2+ and K+. Increased extracellular Ca2+ and K+ 
concentrations inhibited tumor cell growth, and decreased extracellular Ca2+ 
concentrations by chelation with EGTA also induced the inhibition of tumor cell growth. 
7) These ion channel modulators except Ni2+ did not elicit a significant cytotoxicity 
which was assessed by trypan blue exclusion method. 
These results indicate that a variety of ion channel modulators can effectively inhibit 
tumor cell growth and that this growth inhibition is due not to cytotoxicity, but to 
interference of cell proliferation. These results further suggest the potential therapeutic 
applicability of Caz+ and K+ channel-regulating drugs on these tumor cell proliferation. 
The intracellular Ca2+ concentrations were measured in a variety of conditions in 
order to answer the second question. The levels of intracellular Ca2+ were monitored 
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by fluorophotometry using Fura-2 dye. The major findings are: 
1) Carbachol, a muscarinic agonist, increased both cell growth and intracellular Ca2+ 
concentration in U-373 MG human astrocytoma cells. 
2) Carbachol induced a monophasic increase of intracellular Ca2+ concentration, and 
under the condition of 0 extracellular Ca2+ concentration, carbachol elicited a very 
similar response as that in a normal extracellular Ca2+ concentration. 
3) Serum monophasically increased intracellular Ca2+ concentration in SK-N-MC human 
neuroblastoma cells, and this increase was insensitive to the alteration of extracellular 
Ca2+ concentration. 
4) High extracellular K+ or/and Bay K 8644 did not induce the significant alteration of 
intracellular Ca2+ concentration. 
These results indicate that agents which act as growth factors, can induce the 
increased intracellular Ca2+ concentration and that this Ca2+ increase comes not from 
extracellular space but from intracellular stores. These results further suggest that no 
voltage-dependent Ca2+ channels are present and that intracellular Ca2+ mobilization from 
intracellular stores is an important proliferative signalling mechanism of growth factors 
in both model tumor cells. 
In relation to third question, the effects of various Ca2+ and K+ channel modulators 
on agonist-induced intracellular Ca2+ mobilization were investigated in order to elucidate 
the mechanism of their inhibitory actions in tumor cell growth. Carbachol and serum 
were used as agonist for the mobilization of intracellular Ca2+ in U-373 MG human 
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astrocytoma and SK-N-MC human neuroblastoma cell lines, respectively. The results 
are: 
1) The effective growth-inhibitory concentrations of Ca2+ channel antagonists such as 
verapamil, nifedipine, diltiazem and SK&F 96365 inhibited significantly agonist-induced 
intracellular Ca2+ mobilization from intracellular stores in both model tumor cells. 
2) The effective growth-inhibitory concentrations of K+ channel modulators such as TEA, 
4-AP and diazoxide induced significant reduction of increased intracellular Ca2+ 
concentrations induced by agonists in these tumor cells. 
3) These ion channel modulators did not elicit a significant alteration of basal, free 
intracellular Ca2+ concentrations in these tumor cells. 
These results suggest that the growth-inhibitory effects of these ion channel 
modulators may be attributed to their abilities to intervene agonist-induced increased 
intracellular Ca2+ concentration mobilized from internal stores. 
The mechanism of these ion channel modulators in the inhibition of agonist-induced 
Ca2+ mobilization from internal stores was not addressed in this dissertation and remains 
to be determined. However, since membrane potential changes have been demonstrated 
to induce alteration of agonist-induced second messenger generations, these effects of at 
least K+ channel modulators may be explained by their modulation of membrane 
potential. 
In conclusion, intracellular Ca2+ mobilization from internal stores is an essential 
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signalling event in the proliferation of the tumor cells used in this dissertation. Ca2+ and 
K+ channel blockers effectively inhibit agonist-induced Ca2+ mobilization and, thus, 
tumor cell growth. These findings may contribute to the understanding of caner cell 
biology and provide insight into the role of ion channels as therapeutic targets for disease 
management. 
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